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Executive Summary 
Background 
The challenge of providing comprehensive health care of high quality that is 
available to all is shared by universal coverage health care systems of today 
[1]. One of the quality assurance mechanisms is minimum volume standards 
(MVSs). While the majority of research observes a positive association in 
terms of statistical correlation between volume and outcome and infers a 
causal inverse link between the two, data on specific MVS thresholds are 
scarce. Up to recently, they have been all primarily concerned with complex 
and high-risk surgeries mainly conducted in the inpatient setting. 
Currently in Austria, inpatient services including day surgeries are gradual-
ly shifting to the ambulatory setting and so MVSs in the ambulatory surgical 
setting may constitute a supplement to commonly applied and currently de-
veloped quality standards. Analysing the role of MVSs in day surgery is the 
aim of this report. 
Methods 
The present systematic review aimed to investigate whether minimum vol-
ume standards in comparison to no minimum volume standards in the day 
surgery setting lead to better efficacy and safety outcomes. Assessment el-
ements from the EUnetHTA Core Model® for screening technologies 3.0 were 
customised so that they could be used for the purposes of this assessment. 
The systematic literature search was conducted in the following five data-
bases (Medline via Ovid, Embase, The Cochrane Library, CRD (DARE, NHS-
EED, HTA), and Livivo). The search was limited to years 2000 to 2019 and 
to articles published in English or German. After deduplication, overall 538 
citations were found via systematic search and additional 57 via hand search 
– resulting in the total of 595 hits. 
The exploratory literature search for the section on minimum volume stand-
ards was carried out in Google, Google Scholar, and PubMed. Then, a hand 
search in websites of governmental and public bodies, expert societies, and 
other health care stakeholders was carried out.  
Day surgery setting 
The International Association for Ambulatory Surgery defines day surgery as 
a practice where patients are admitted, operated on, and discharged during 
the time frame of one working day (six to eight hours), with no overnight stay 
[2]. The EU observatory as well as the British Association for Day Surgery 
further add that “true” day surgery includes planned non-emergency surgi-
cal procedures on carefully-selected and prepared patients that are intended 
to be treated in the day surgery setting [3, 4].  
The present definition from the Austrian Target-Based Governance (Vertrag zur 
Zielsteuerung-Gesundheit auf Bundesebene – B-ZV) states that day surgery 
refers to the hospital care for patients who receive an intervention from the 
catalogue of daily reimbursed interventions (according to the Austrian DRG 
System – LKF model) and are admitted and discharged on the same day [5]. 
However, because the Austrian health care system is complex and fragment-
ed, day surgery is regulated differently depending on the setting and the cor-
responding legal authority responsible for the premises where it takes place. 
MVSs thresholds  
as a quality assurance 
mechanism 
gradual shift from 
inpatient setting to  
day surgery 
aim: investigate  
if MVSs bring about 
better outcomes in  
day surgery, EUnetHTA 
Core Model® used 
systematic search  
in five databases, 
articles in English and 
German, total 595 hits 
search for the  
MVSs chapter in  
3 databases plus  
hand search 
international definitions 
of day surgery 
Austrian definition  
of day surgery and  
the challenge of the 
Austrian fragmented 
health care system 
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Minimum volume standards 
Understanding the volume-outcome relationship 
On the one hand, practice makes perfect seems the most intuitive approach ex-
plaining the volume-outcome relationship (VOR). The purported hypothesis 
presumes that physicians, non-physician staff, or hospitals improve their (sur-
gical) capabilities and outcomes with increasing volume of patients through 
a learning effect [6]. The expected causality here is clear: quantity affects 
quality. 
On the other hand, another approach explaining the link between volume 
and outcome is called selective referral. This purported hypothesis assumes 
that high-quality service providers are more likely to accumulate a large pro-
portion of overall conducted services because patients are more likely to seek 
these providers in the first place [7]. Hence, volume depends on outcome or 
the provider’s (initial) quality. Both hypotheses seem to be valid in the em-
pirical literature [8]. 
Description of MVSs and current use 
Besides further quality standards, stakeholders in the health care sector have 
promoted the implementation of a (regulatory) MVSs framework. The goal 
of MVSs is to assure that surgeons or hospitals that comply with the mini-
mum volume of surgeries provide a certain level of quality [9]. A possible con-
sequence of not complying with these minimum requirements – but mostly 
rarely enforced – is that surgeries are not reimbursed anymore [10].  
Various countries have already implemented MVSs in hospitals for selected 
complex and high-risk surgeries for quality and safety reasons. Among the 
countries that provide a MVSs framework in the inpatient setting are Ger-
many, Canada, the Netherlands, Switzerland and Austria [10]. According to 
the identified literature, the hand and exploratory search, no country, except 
for Germany seems to have specific threshold values for day or ambulatory 
surgery in force [11, 12].  
The literature on the VOR, however, provides no universally solid method to 
specify administrative MVS thresholds [13, 14]. Generally, modelling ap-
proaches on the basis of regression models seem to be most appropriate, but 
the choice of the appropriate model depends on the specific problem and the 
available data [15, 16]. Most of the studies implementing regression models 
neglect methodical issues associated with the calculation of thresholds that 
consequently affect the reliability of the thresholds as discussed above [13, 
17]. 
In terms of the mechanism of action, MVSs claim to improve both quality 
aspects as well as economic aspects. In the context of the Donabedian model, 
MVSs target the structural quality and are seen as an intermediate step to in-
crease quality of outcome [18]. It is expected that implementation of MVSs 
improves the level of training and the abilities of the surgical personnel as 
well as the management abilities of care units. However, patient-related fac-
tors and process related factors such as overall preoperative preparation, an-
aesthetic management, postoperative recovery and discharge, or follow-up are 
other factors not influenced by MVSs that are equally relevant for successful 
and high-quality day surgeries [19, 20]. In terms of economic aspects, MVSs 
are, in theory, expected to increase production efficiency through a learning 
effect and reduce costs via economies of scale. 
practice makes perfect 
as the intuitive 
approach where 
quantity leads to quality 
selective referral as a 
competing approach 
that assumes that 
quality draws quantity 
(inverse causality) 
MVSs in place as a 
quality assurance 
measure 
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Results 
Available evidence 
For the assessment of clinical effectiveness, eight studies met the inclusion 
criteria and reported seven different interventions. The interventions at stake 
in the current assessment were not predefine, but were selected based upon 
the systematic literature search. The indications are thyroid surgery (thyroid-
ectomy), cataract surgery, primary hip arthroscopy, open carpal tunnel re-
lease, rotator cuff repair, anterior cruciate ligament reconstruction, and me-
niscectomy. One of the studies had a control group [21], however, none of 
the studies was done prospectively – all the studies were retrospective. While 
two studies were single centre analyses [21, 22], the remaining six studies were 
analyses of health care databases [23-28]. Seven studies were conducted in the 
US [21-26, 28] and the eighth study was conducted in the Netherlands [27]. 
Information about study sponsors was not disclosed in five studies [21-23, 25, 
26], two studies were funded by the National Institutes of Health/National 
Institute for Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) 
[27, 28], and one study was funded by the National Eye Institute (NEI) [24]. 
All the studies gathered data on the outpatient setting and while four studies 
analysed the VOR from the perspective of surgeons [22, 24, 27, 28], one ana-
lysed it from the hospital perspective [23], and three from the perspectives 
of both surgeons as well as hospitals [21, 25, 26]. Follow-up time was not re-
ported in five studies [21, 22, 24-26], it was ten years in [28], six months in 
[27], and 30 days in [23]. In terms of patient population, primary hip ar-
throscopy included 7,836 patients [28], carpal tunnel release included 1,345 
patients [27], rotator cuff repair included 9,973 patients [25], anterior cruci-
ate ligament (ACL) reconstruction included 45,262 patients [23, 26], menisc-
ectomy included 123,012 patients [26], thyroidectomy included 109 outpatient 
patients [21], and cataract surgery included 2,289,307 patients [22]. Surgeon 
as well as hospital volume was categorised into low, medium, and high (very 
high in one study [28]) and the thresholds differed with interventions. 
Clinical effectiveness 
Concerning thyroidectomy, there was no VOR observed, but it was suggested 
that thyroidectomy is safe also in low volume centers as in the only low vol-
ume center, no cases of readmission occurred [21]. 
Concerning cataract surgery, the number of cases per surgeon was inversely 
correlated with the adverse event of posterior capsule rupture (PCR) where 
PCR and vitreous loss rate were 3.75% for low volume and 0.29% for very 
high volume surgeons [22]. The difference in relative risk for endophtalmitis 
was 4-fold between low and very high volume surgeons [24]. 
Concerning hip arthroscopy, the survival rates for very high volume surgeons 
were 11.1-24.9% higher than for low volume and the hazard ratio for reoper-
ation (with reference value of low volume) was 0.17 for very high volume sur-
geons [28]. 
Concerning open carpal tunnel release, BCTQ score did not vary with vol-
ume at all while the difference on the VAS scale was 1 point (out of 100) be-
tween low and high volume surgeons (18 vs. 19 points) [27]. Such difference 
is below the threshold of the minimal clinically important difference [29]. 
Concerning rotator cuff repair, patients of low volume surgeons were 2.8 time 
more likely to have non-routine disposition at discharge, while low volume 
hospitals were 2.1 times more likely to discharge patients with non-routine 
8 studies included  
in the analysis,  
7 different interventions 
 
all studies were 
retrospective 
 
7 studies conducted in 
the US, one in the 
Netherlands 
 
3 studies sponsored 
VOR analysed  
from surgeon/hospital 
perspectives, follow-up 
not reported in 5 studies 
 
large patient sample 
included in all the 
studies – except for 
thyroidectomy 
no VOR observed  
in thyroidectomy 
VOR observed  
in cataract surgery 
VOR observed  
in hip arthroscopy 
no VOR observed  
in open carpal tunnel 
release 
VOR observed in  
rotator cuff repair 
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dispositions. Surgeon-related mean operating time was 10 minutes shorter and 
hospital-related mean operating time was 6 minutes shorter for high volume 
compared to low volume surgeons/hospitals. The length of stay (LOS) was 
2.3 times longer for low volume surgeons and 0.5 times for low volume hos-
pitals compared to high volume surgeons/hospitals [25].  
Concerning anterior cruciate ligament (ACL) reconstruction, the odds ratio 
for hospital based acute care within 30 days (with reference of low volume 
hospitals) was 0.47 for high volume hospitals [23]. Low volume surgeons were 
4.5 times more likely and low volume hospital 3.33 times more likely to have 
non-routinely discharged patients compared to high volume surgeons [26]. 
Furthermore, low volume surgeons had a 27 minutes longer and low volume 
hospitals 21 minutes longer mean operating time than high volume surgeons/ 
hospitals [26]. 
Concerning meniscectomy, low volume surgeons were 2.8 times and low vol-
ume hospitals were 8 times more likely to have non-routinely disposed pa-
tients at discharge than high volume surgeons/hospitals [26]. In terms of mean 
operating time, both low volume surgeons and low volume hospitals had a 
longer mean operating time by 19 minutes compared to high volume sur-
geons/hospitals [26]. 
Safety 
The only safety related data reported were without its relationship to surgeon/ 
hospital volume. In the hip arthroscopy study, 0.2% of patients experienced 
procedural complication at 30 days post intervention [28]. In the carpal tun-
nel release study, 1.6% of patients experienced procedural complications [27], 




The quality assessment of individual studies was done using the ISPOR Task 
Force Checklist for Quality Assessment of Retrospective Database Studies 
[30]. Concerning effectiveness and safety of MVSs, the quality of the evidence 
base is very low. The main reasons are the retrospective design of all the 
studies [21-28], the lack of justification for its use [21, 22, 25-27], or the lack 
of a priori data analysis plan [21-28]. Further reasons include unclear eligi-
bility criteria [21-23, 27, 28], lack of justification for the statistical models 
used [21-23, 25-28], lack of interpretation of the statistical findings in terms 
of their clinical or economical evidence [22, 23, 25-28], and limited recogni-
tion of the generalisability of the retrospective study design [21, 22, 25-27]. 
Due to these gaps in evidence, the relevance of the current evidence base to 
relative effectiveness assessment of MVSs is questionable. Retrospective da-
tabase analyses do not fulfil the evidence-based medicine standards as they 
are prone to a spectrum of biases. For that reason, their conclusions are ap-
plicable only in part. In their favour plays the relatively robust body of evi-
dence from the inpatient setting, relatively high number of patients includ-
ed in the day surgery studies, and studies supporting no significant difference 
in outcomes between the settings [3]. Against it plays the poor internal and 
external validity of the present evidence base and the critical considerations 
related to MVSs in general. Generalisability of the data is put in question be-
cause all the studies (except for [27]) were conducted in the USA where the 
definition of day surgery and outpatient surgery may vary [20]. 
VOR observed in  
ACL reconstruction 
VOR observed in 
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no VOR data  
on safety 
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When conducting volume-outcome analysis, one has to be cautious not to fall 
in a mono-causal or reverse causality trap when establishing links between 
two or more variables. An observed correlation does not necessarily indicate 
causation. Against this backdrop, it is important to synthesise the various 
approaches to emphasise the complexity of the VOR and its derived policies. 
The two approaches – practice makes perfect and selective-referral – imply sig-
nificantly different policy choices [8]. While the practice makes perfect hypoth-
esis gives reasonable arguments to implement a (regulatory) framework in 
the form of MVSs, the selective referral approach would indirectly appeal to 
healthcare research to understand why phenomena such as centralisation of 
services in form of volume accumulation of a few hospitals came up in the 
first place. 
In terms of limitations of the present systematic review, we only found VOR 
data on eight interventions, which, however, is not a representative sample of 
all the interventions eligible for day surgery. Furthermore, the following stud-
ies on arthroscopy, meniscal repair, and colonoscopy [31-33] were excluded 
from the analysis even though they met the inclusion criteria. The reason was 
that they were found in an additional search in the end stage of the report 
when including them was no longer feasible. Additional reason for not in-
cluding them was their assumed low marginal utility as quality of all studies 
was low due to their retrospectives study design. 
 
Conclusion 
The need for a shift of surgical interventions from the inpatient setting to the 
day surgery setting is advocated in the international literature. Because the 
VOR does have some standing in the inpatient setting, the role of MVSs ap-
plied to the day surgery setting was scrutinised in this report. Besides the the-
ory of MVSs, we aimed to provide the data on international variations and 
current use of MVSs with a particular focus on the German context. There is 
no consensus behind the theory of MVSs, and also the results from our sys-
tematic review cannot offer any clear-cut MVS thresholds. This present re-
port, however, provides some evidence in favour of VOR, even though it based 
on low quality retrospective data-analyses. The low quality of the retrospec-
tive evidence found does not establish the clear presence of the VOR nor any 
clear MVSs. Two out of eight studies did not suggest a VOR at all. For these 
reasons, we argue that the application of MVSs should be well thought out. 
Moreover, because establishing the VOR and henceforth the MVSs is possi-
ble, quality prospective controlled evidence for the day surgery setting is re-
quired. Also, other quality assurance standards such as standards focusing 
on process and outcome quality should be taken into account. 
  
VOR can be plausibly 
explained via practice 
makes perfect as well  
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hypotheses, hence 
caution required when 
applying MVSs 
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Zusammenfassung 
Hintergrund 
Der Herausforderung, eine umfassende und qualitativ hochwertige Gesund-
heitsversorgung anzubieten, die in gleicher Weise für alle zugänglich ist, müs-
sen sich die heutigen flächendeckenden Gesundheitssysteme gleichermaßen 
stellen [1]. Eine mögliche Maßnahme zur Qualitätssicherung stellen dabei 
Mindestmengen (MM) dar. Während der Großteil der Forschung einen posi-
tiven Zusammenhang in Form von statistischer Korrelation zwischen Leis-
tungsmenge und Ergebnis beobachten kann und einen kausalen inversen Zu-
sammenhang zwischen beiden ableitet, ist die Verfügbarkeit von Daten über 
spezifische und evidenzbasierte MM-Schwellenwerte gering. Bislang lag der 
Fokus der Forschung im Kontext von MM auf komplexen und risikoreichen 
Operationen, die überwiegend im stationären Bereich durchgeführt werden. 
In Österreich ist derzeit eine schrittweise Verlagerung von stationären Leis-
tungen einschließlich der Tageschirurgie in den ambulanten Bereich, zu be-
obachten. MM im ambulanten Bereich für tageschirurgische Eingriffe kön-
nen möglicherweise eine Ergänzung zu den allgemein angewandten und ak-
tuell entwickelten Qualitätsstandards darstellen. Der vorliegende Bericht hat 
das Ziel einer kritischen Analyse von MM in der Tageschirurgie. 
 
Methoden 
Die vorliegende systematische Übersichtsarbeit zielte darauf ab, zu untersu-
chen, ob MM im Vergleich zu keinen MM in der Tageschirurgie zu besseren 
Ergebnissen hinsichtlich der Wirksamkeit und Sicherheit führen. Im Zuge 
der Analyse wurden Bewertungselemente aus dem EUnetHTA-Core Model® 
für Screening-Technologien 3.0 dahingehend adaptiert, dass sie für die Zwe-
cke dieser Bewertung verwendet werden können. 
Die systematische Literaturrecherche wurde in folgenden fünf Datenbanken 
durchgeführt: Medline via Ovid, Embase, The Cochrane Library, CRD (DARE, 
NHS-EED, HTA) und Livivo. Der Untersuchungszeitraum wurde auf die Jah-
re 2000 bis 2019 und auf Artikel in englischer oder deutscher Sprache be-
schränkt. Nach der Deduplizierung wurden insgesamt 538 Zitate über die sys-
tematische Suche und weitere 57 über die manuelle Suche gefunden – insge-
samt 595 Treffer. 
Die explorative Literaturrecherche für die Abschnitte über die MM und über 
die Mengen-Ergebnis-Beziehung (MEB) wurde in Google, Google Scholar 
und PubMed durchgeführt. Anschließend wurde eine Handsuche auf Web-
seiten von behördlichen, staatlichen und öffentlichen Einrichtungen, Fach-
gesellschaften und anderen Interessengruppen und AkteurInnen im Gesund-
heitswesen durchgeführt – mit Beschränkung auf Informationen auf Deutsch 
und Englisch. 
 
Tageschirurgie (ambulantes Operieren) 
Die internationale Vereinigung für ambulantes Operieren (International As-
sociation of Ambulatory Surgery – IAAS) definiert Tageschirurgie als eine 
Praxis, in der PatientInnen innerhalb eines Werktages (sechs bis acht Stun-
den) ohne Übernachtung aufgenommen, operiert und entlassen werden [2]. 
Das EU-Observatory sowie die British Association for Day Surgery (BADS) 
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fügen hinzu, dass die „echte“ Tageschirurgie geplante chirurgische Eingriffe 
an sorgfältig ausgewählten und vorbereiteten PatientInnen umfasst – d. h. 
keine Notfälle [3, 4]. 
Die Definition von Tageschirurgie (Tagesklinik) im aktuellen Vertrag zur 
Zielsteuerung-Gesundheit auf Bundesebene (B-ZV) besagt, dass sich die Ta-
geschirurgie (Tagesklinik) auf PatientenInnen im Krankenhauskontext be-
zieht, die eine Intervention gemäß dem österreichischen DRG-System bzw. 
LKF-Modell erhalten, am selben Tag aufgenommen und entlassen werden 
[5]. Aufgrund der Komplexität und Fragmentierung des österreichischen Ge-
sundheitssystems sind tageschirurgische Leistungen inklusive ambulanter 
Operationen, je nach Setting und je nachdem wie die rechtlichen Befugnisse 
bzw. Zuständigkeiten sind, unterschiedlich geregelt. 
Die Gründe für eine Verlagerung von stationären operativen Leistungen in 
den tageschirurgischen bzw. ambulanten Bereich sind vielfältig und können 
organisatorische, ethische, wirtschaftliche und medizinische Gründe umfas-
sen. Mögliche Zielvorstellungen sind ebenfalls vielfältig. Beispielsweise wird 
durch eine Verschiebung versucht, Versorgungspfade zu verbessern bei gleich-
zeitiger Gewährleistung der Verteilungsgerechtigkeit und der Sicherstellung 
eines wirtschaftlichen Umgangs mit Ressourcen. Tageschirurgische Leistun-
gen ermöglichen es den PatientInnen, ihre Umgebung für die Genesung selbst 
zu wählen. Zusätzlich ist die Tageschirurgie möglicherweise mit kürzeren 
Wartezeiten und einem möglichen geringeren Ausfallsrisiko seitens der Pati-
entInnen verbunden [20]. Des Weiteren wird beansprucht, dass die Rate der 
im Krankenhaus erworbenen Infektionen (nosokomiale Infektionen) und ve-
nösen Thromboembolien reduziert werden kann [20]. Darüber hinaus scheint 
ein Übergang zur Tageschirurgie zu einer potentiellen Win-Win-Situation für 
alle Beteiligten zu führen [20]. Der Wegfall von Übernachtungs- und Wo-
chenendaufenthalten kann sowohl für die PatientInnen als auch für das Be-
handlungsteam von Vorteil sein, da es über diese Zeiträume nicht am Be-




Auf der einen Seite scheint die Erklärung Übung macht den Meister (Prac-
tice makes perfect) der intuitivste Ansatz zu sein, um einen Zusammenhang 
zwischen Leistungsmengen und Ergebnis, kurz Mengen-Ergebnis-Beziehung 
(MEB), zu erklären. Bei der Hypothese wird davon ausgegangen, dass durch 
eine zunehmende Leistungsmenge und damit assoziierten Lerneffekten Ärz-
tInnen, nichtärztliches Personal oder Krankenhäuser ihre (chirurgischen) Fä-
higkeiten und Ergebnisse verbessern [6]. Der erwartete Wirkungsmechanis-
mus (Kausalität) bei dieser Hypothese liegt auf der Hand: Quantität beein-
flusst Qualität.  
Auf der anderen Seite gibt es einen weiteren Erklärungsansatz, der den Zu-
sammenhang zwischen Leistungsvolumen und Ergebnis herstellt: selektive 
Überweisung bzw. Selective referral. Diese Hypothese geht davon aus, dass 
qualitativ hochwertige Leistungserbringer eine höhere Leistungsmenge bzw. 
Fallzahl akkumulieren, da die PatientInnen eher qualitativ hochwertige Leis-
tungserbringer aufsuchen [7]. Die erbrachte Leistungsmenge bzw. die Fall-
zahl hängt also vom Ergebnis oder der (Erst-)Qualität des Leistungsanbieters 
ab. Beide Hypothesen scheinen in der empirischen Literatur gültig zu sein [8]. 
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Mindestmengen und derzeitige Anwendung 
Neben weiteren Qualitätsstandards fordern und fördern AkteurInnen im Ge-
sundheitswesen die Umsetzung eines (regulatorischen) MM-Rahmens. Erklär-
tes Ziel von MM ist es sicherzustellen, dass ChirurgInnen oder Krankenhäu-
ser, die die MM an chirurgischen Eingriffen erfüllen, ein gewisses (besseres) 
Qualitätsniveau erreichen [9]. Eine mögliche Konsequenz bei Nichteinhal-
tung dieser Mindestanforderungen – jedoch meist selten durchgesetzt – ist, 
dass die spezifischen Operationen nicht mehr erstattet werden [10] 
Verschiedene Länder haben bereits MM für ausgewählte komplexe und risi-
koreiche Operationen im Krankenhauskontext aus Qualitäts- und Sicherheits-
gründen implementiert. Zu den Ländern, die einen MM-Rahmen im statio-
nären Bereich anbieten, gehören Deutschland, Kanada, die Niederlande, die 
Schweiz und Österreich [10]. Auf Basis der identifizierten Literatur, der Hand-
suche und explorativen Suche scheint kein Land, außer Deutschland, spezi-
fische Schwellenwerte für tageschirurgische Leistungen bzw. ambulante Ope-
rationen in Kraft zu haben [11, 12]. 
Die Literatur zur MEB bietet jedoch keine universelle solide Methode zur 
Festlegung administrativer MM [13, 14]. Im Allgemeinen erscheinen Model-
lierungsansätze auf der Grundlage von Regressionsmodellen am besten ge-
eignet zu sein. Allerdings hängt die Wahl des geeigneten Modells vom spezi-
fischen Problem und der verfügbaren Datenlage ab [15, 16]. Die meisten der 
Studien, die Regressionsmodelle verwenden, vernachlässigen methodische 
Fragen im Zusammenhang mit der Berechnung von Schwellenwerten. Diese 
Limitationen wirken sich auf die Zuverlässigkeit der Schwellenwerte aus [13, 
17]. 
Grundsätzlich sollte nur ein qualitativ hochwertiger Evidenzkörper (prospek-
tive und kontrollierte Studien), der einen robusten Zusammenhang zwischen 
Leistungsvolumen und Ergebnis bzw. Endpunkt herstellt, herangezogen wer-
den, um administrative MM als Qualitätsstandard zu implementieren. Unter 
einem robusten Zusammenhang von Leistungsvolumen und Ergebnis wird 
ein Zusammenhang verstanden, der eine hohe klinische Relevanz aufweist, 
der plausibel, logisch, auf der Grundlage strenger statistischer Kriterien durch 
eine Reihe von Studien, die einen konsistenten statistischen Zusammenhang 
eindeutig belegen, verifiziert wurde. Diese Definition steht im Einklang mit 
den neun Bradford-Hill-Kriterien, die bei der Herleitung potenzieller kausa-
ler Zusammenhänge herangezogen werden und auch vom National Cancer 
Policy Board in den USA verwendet werden [7, 34]. 
Im Hinblick auf den Wirkungsmechanismus haben MM den Anspruch, Er-
gebnisse hinsichtlich qualitativer als auch wirtschaftlicher Aspekte zu ver-
bessern. Im Kontext des Qualitätsmodells nach Donadebian können MM in 
die strukturelle Qualitätsdimension eingeordnet werden. MM werden dabei 
als ein Zwischenschritt zur Steigerung der Ergebnisqualität angesehen [18]. 
Die erwarteten Effekte von MM umfassen einen höheren Ausbildungsgrad, 
eine Verbesserung der Fähigkeiten des chirurgischen Personals sowie eine 
Steigerung der Managementfähigkeiten von Krankenhäusern und Pflegeein-
richtungen. PatientInnen- und prozessbezogene Faktoren – wie die gesamte 
präoperative Vorbereitung, das Anästhesiemanagement, die postoperative Ge-
nesung und die Entlassung bzw. die Nachsorge – sind jedoch weitere Fakto-
ren, die zwar nicht von MM beeinflusst werden, aber für eine erfolgreiche 
und qualitativ hochwertige Durchführung von tageschirurgischen Leistungen 
gleichermaßen relevant sind [19, 20]. Die erwarteten ökonomischen Aspekte 
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effekt und eine Kostenreduktion durch Skaleneffekte, welches beiderseits zu 
niedrigeren langfristigen Kosten führen kann und mit Leistungszentralisie-
rungen bzw. mit Bildungen von Exzellenzzentren verbunden ist. 
Auf einer aggregierten (sozialen) Wohlfahrtsebene kann ein möglicher durch 
MM induzierter Zentralisierungseffekt chirurgischer Leistungen jedoch nur 
dann von Nutzen und nachhaltig sein, wenn sich die Ergebnisse für Patien-
tInnen in der gesamten Bevölkerung verbessern bzw. zumindest für nieman-
den verschlechtern. Ein kritischer Aspekt bei Leistungszentralisierungen auf-
grund von MM betrifft eine mögliche Verschlechterung der Versorgungsqua-
lität (Verfügbarkeit bzw. Zuverlässigkeit). Zentralisierungen könnten die Un-
gleichheiten beim Zugang zu hochwertiger Versorgung, in Form von größeren 
Entfernungen zur nächsten Versorgungseinrichtung, vergrößern. Dies scheint 
besonders für vulnerable Gruppen, wie Menschen mit sozioökonomischen 
Benachteiligungen oder älteren Menschen, wichtig zu sein. Diese Personen-
gruppen erfahren nicht nur in Bezug auf die Entfernung einen eingeschränk-
ten Zugang zur Gesundheitsversorgung. Darüber hinaus könnte die Zentra-
lisierung die eigenständige Wahl der PatientInnen beeinträchtigen, da sie in 
diesem Fall kaum oder gar keine Wahlmöglichkeiten zwischen verschiede-
nen Gesundheitseinrichtungen haben. 
Organisatorische Aspekte und Implikationen im österreichischen Kontext 
Die Festlegung von Grundprinzipien zur Stärkung der Umsetzung von Qua-
litätsnormen ist von zentraler Bedeutung [35, 36]. International gibt es etab-
lierte Programme zur Bestimmung von Qualitätsstandards, wie beispiels-
weise jene von Health Quality Ontario (HQO) und NICE [36, 37]. In Öster-
reich hat die GÖG GmbH im Auftrag des Bundesministeriums für Arbeit, 
Soziales, Gesundheit und Konsumentenschutz (BMASGK) kürzlich eine ak-
tualisierte Version ihres methodischen Handbuchs zur Erstellung von Qua-
litätsstandards auf der Grundlage der genannten Prozessleitfäden von NICE 
und HQO veröffentlicht [38]. Das Handbuch schlägt ein dreistufiges Ver-
fahren zur Entwicklung von Qualitätsstandards vor: Festlegung der Kernele-
mente des jeweiligen Standards, Erstellung der Qualitätsstandards sowie poli-
tische und organisatorische Umsetzung einer Qualitätsnorm. Nach Abschluss 
der Qualitätsstandards müssen auch noch einige nachgelagerte Prozesse wie 
Monitoring berücksichtigt werden. 
Regelung der Tageschirurgie in Deutschland – ambulantes Operieren 
In Deutschland kann mittlerweile ein breites Spektrum an chirurgischen Ein-
griffen ambulant bzw. auf tagesklinischer Basis auch von (Vertrags-)ÄrztIn-
nen im niedergelassenen Bereich durchgeführt werden. Dazu gehören Arth-
roskopien, Kataraktoperationen, Biopsien und mehr. Darüber hinaus haben 
sich die gesetzliche Krankenversicherung (GKV), die Deutsche Krankenhaus-
gesellschaft (DKG) und die Kassenärztliche Bundesvereinigung (KBV) ver-
traglich darauf geeinigt, die ambulante Chirurgie zu stärken und chirurgi-
sche Eingriffe im stationären Bereich zu ersetzen. Der so genannte AOP-Ver-
trag soll einen einheitlichen Rahmen für die Durchführung von ambulanten 
Operationen und stationsersetzenden Verfahren schaffen. Zusätzlich soll die 
Zusammenarbeit zwischen dem niedergelassenen Bereich und dem Kranken-
haussektor unterstützt werden. Der Vertrag legt darüber hinaus fest, dass 
eine erfolgreiche Zulassung an Auflagen gebunden ist: So müssen für das 
Operieren im ambulanten Bereich – für spezifische tageschirurgische Ein-
griffe - Mindestanforderungen gemäß FachärztInnenstand erfüllt sein. Die 
chirurgischen Mindestvolumenanforderungen für die Erlaubnis zur Durch-
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führung der spezifischen Operation und die Frequenzanforderungen (jährli-
che Mindestmengen) zur Fortsetzung der spezifischen Operation sind in ent-
sprechenden Qualitätsvereinbarungen neben der Rahmenvereinbarung „Qua-
litätssicherungsmaßnahmen nach § 135 Abs. 2 SGB V für das ambulante Ope-
rieren“ festgelegt. Die drei Parteien (GKV, DKG und KBV) einigten sich auch 
auf eine entsprechende einheitliche Vergütung für Krankenhäuser und KBV-
VertragsärztInnen. Alle für das ambulante Operieren relevanten tageschirur-
gischen Eingriffe sind im AOP-Katalog aufgeführt. Darüber hinaus gibt es 
regionale Verträge, die den Spielraum für Krankenkassen und die 17 Kassen-
ärztlichen Vereinigungen erweitern sollen. Dazu gehören differenzierte Ge-
bührensysteme, aber auch zusätzliche Mindestvolumen- und Frequenzanfor-
derungen können Teil dieser Verträge sein. 
 
Ergebnisse der systematischen Übersichtsarbeit 
Verfügbare Evidenz 
Zur Beurteilung der klinischen Wirksamkeit im vorliegenden Bericht erfüll-
ten acht Studien mit sieben verschiedenen Interventionen die Einschlusskri-
terien. Die Interventionen wurden nicht vordefiniert, sondern auf Grundla-
ge der systematischen Literaturrecherche identifiziert. Die Indikationen sind 
Schilddrüsenoperation (Thyreoidektomie), Kataraktoperation, primäre Hüft-
arthroskopie, offene Karpaltunnelspaltung, Reparatur der Rotatorenmanschet-
te, Rekonstruktion des vorderen Kreuzbandes (LCA) und Meniskektomie. 
Eine der Studien beinhaltete eine Kontrollgruppe [21], jedoch wurde keine 
der Studien prospektiv durchgeführt – alle Studien waren retrospektiv. Wäh-
rend zwei Studien Single-Center-Studien waren [21, 22], handelte es sich bei 
den restlichen sechs Studien um Analysen mit (administrativen) Daten aus 
dem Gesundheitswesen [23-28]. Sieben Studien wurden in den USA durchge-
führt [21-26, 28] und die achte Studie wurde in den Niederlanden durchge-
führt [27]. Informationen über die Finanzierung der Studien wurden in fünf 
Studien nicht berichtet [21-26, 25, 26], zwei Studien wurden vom National 
Institutes of Health/National Institute of Arthritis and Musculoskeletal and 
Skin Diseases (NIH/NIAMS) finanziert [27, 28], und eine Studie wurde vom 
National Eye Institute (NEI) finanziert [24]. 
Alle Studien sammelten Daten für den ambulanten Bereich. Während vier 
Studien die Mengen-Ergebnis-Beziehung (MEB) aus ChirurgInnensicht ana-
lysierten [22, 24, 27, 28], analysierte eine Studie die MEB aus Krankenhaus-
sicht [23]. Drei Studien berücksichtigen sowohl die Leistungsmenge aus Chi-
rurgInnensicht als auch die Leistungsmenge aus Krankenhaussicht [21, 25, 
26]. In fünf Studien wurde die Länge des Follow-Ups nicht berichtet [21, 22, 
24-26], in einer Studie betrug die Länge des Follow-Ups zehn Jahre [28], sechs 
Monate in [27] und 30 Tage in [23]. In Bezug auf die PatientInnenpopulation 
umfasste die primäre Hüftarthroskopie 7.836 PatientInnen [28], die offene 
Karpaltunnelspaltung 1.345 PatientInnen [27], die Reparatur der Rotatoren-
manschette 9.973 PatientInnen [25], die LCA-Rekonstruktion 45.262 Patien-
ten [23, 26], die Meniskusoperation 123.012 PatientInnen [26], die Schilddrü-
senenoperation 109 PatientInnen [21] und die Kataraktoperation 2.289.307 
PatientInnen [22]. Die Leistungsmenge der ChirurgInnen als auch das Kran-
kenhausvolumen wurden in drei bzw. vier Kategorien eingeteilt (niedrige, 
mittlere und hohe bzw. in einer Studie sehr hohe Leistungsmenge [28]). Die 
Schwellenwerte bzw. Intervalle der Kategorien unterschieden sich bei allen 
Interventionen. 
8 Studien wurden in die 
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Klinische Wirksamkeit 
Bei der Schilddrüsenresektion wurde keine MEB beobachtet, aber es wurde 
darauf hingewiesen, dass eine Schilddrüsenresektion auch in Zentren mit ge-
ringem Leistungsvolumen sicher durchgeführt werden kann, da kein Fall von 
Wiederaufnahme auftrat [21]. 
Bei der Kataraktoperation war die Leistungsmenge pro ChirurgIn negativ mit 
dem Auftreten einer Ruptur der hinteren Linsenkapsel (PCR) korreliert. Die 
Rate einer PCR bzw. Rate eines Glaskörperverlusts bei niedriger Leistungs-
menge betrug 3,75% und 0,29% bei hoher Leistungsmenge [22]. Das relative 
Risiko einer Endophthalmitis war bei ChirurgInnen mit niedriger Leistungs-
menge 4-fach höher als bei jenen mit hoher Leistungsmenge [24]. 
Bei der Hüftarthroskopie gestaltete sich die Überlebensrate der PatientInnen 
von ChirurgenInnen mit sehr hohen Leistungsmengen 11,1-24,9% höher als 
bei ChirurgInnen mit einer niedrigen Leistungsmenge. Der Risikoquotient 
(Hazard Ratio) für Reoperationen betrug 0,17 für sehr hohe Leistungsmen-
gen (Referenzwert: niedrige Leistungsmengen) [28]. 
Bei der offenen Karpaltunnelspaltung hatte die Leistungsmenge keinerlei 
Einfluss auf den BCTQ-Score. Der Unterschied auf der Visuellen Analog-
skala (VAS) belief sich auf einen Punkt (von 100) zwischen ChirurgInnen mit 
niedriger und hoher Leistungsmenge (18 vs. 19 Punkte) [27]. Diese Differenz 
liegt unter der Schwelle der minimalen klinisch wichtigen Differenz [29]. 
Bei der Reparatur der Rotatorenmanschette war die Wahrscheinlichkeit nicht 
routinemäßiger Dispositionen bei Entlassung für PatientInnen von Chirur-
gInnen mit niedrigem Leistungsvolumen 2,8-mal höher als von jenen mit ho-
her Leistungsmenge. Krankenhäuser mit niedrigem Leistungsvolumen ent-
ließen 2,1-mal wahrscheinlicher PatientInnen mit einer nicht routinemäßigen 
Disposition als jene mit hoher Leistungsmenge. Die durchschnittliche Ope-
rationszeit war bei ChirurgInnen mit hohen Leistungsmengen im Vergleich 
zu ChirurgInnen mit einem niedrigen Leistungsvolumen um 10 Minuten kür-
zer. Krankenhäuser mit hoher Leistungsmenge benötigten hinsichtlich der 
mittleren Operationszeit 6 Minuten weniger als jene mit niedrigem Volumen. 
Lost to Follow-Up war bei ChirurgInnen mit niedriger Leistungsmenge 2,3-
mal länger und bei Krankenhäusern 0,5-mal länger als bei ChirurgenInnen/ 
Krankenhäusern mit hoher Leistungsmenge [25]. 
Das Quotenverhältnis (Odds Ratio) zwischen Krankenhäusern mit hoher Leis-
tungsmenge und jenen mit niedriger Leistungsmenge betrug bei der LCA-
Rekonstruktion – für eine stationäre Akutversorgung innerhalb von 30 Tagen 
– 0,47. [23]. Nicht routinemäßig entlassene PatientInnen waren bei Chirur-
gInnen mit niedrigem Leistungsvolumen 4,5-mal wahrscheinlicher (bei Kran-
kenhäusern mit niedrigem Volumen 3,33-mal wahrscheinlicher) als bei Chi-
rurgInnen/Krankenhäusern mit hoher Leistungsmenge [26]. Darüber hinaus 
war die durchschnittliche Operationszeit von ChirurgInnen und Kranken-
häusern mit niedriger Leistungsmenge um 27 Minuten bzw. 21 Minuten län-
ger als die der ChirurgInnen/Krankenhäuser mit hoher Leistungsmenge [26]. 
In Bezug auf die Meniskektomie wiesen ChirurgInnen und Krankenhäuser 
mit niedriger Leistungsmenge eine um 2,8-fach bzw. 8-fach höhere Wahr-
scheinlichkeit auf, PatientInnen mit einer nicht routinemäßigen Dispositi-
on bei der Entlassung zu haben als Chirurgen/Krankenhäuser mit einer ho-
hen Leistungsmenge [26]. In Bezug auf die mittlere Operationszeit hatten so-
wohl niedervolumige ChirurgInnen als auch niedervolumige Krankenhäuser 
eine um 19 Minuten längere mittlere Operationszeit als hochvolumige Chi-
rurgen/Krankenhäuser [26]. 
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Sicherheit 
Die berichteten Daten hinsichtlich der Sicherheit wurden nicht mit der Leis-
tungsmenge der ChirurgIn/Krankenhauses in Bezug gesetzt und analysiert. 
In der Studie zur Hüftarthroskopie erlebten 0,2% der PatientInnen 30 Tage 
nach der Operation eine verfahrensbezogene Komplikation [28]. In der Stu-
die zur Karpaltunnelspaltung erlitten 1,6% der PatientInnen prozedurbezo-
gene Komplikationen [27] und in der Studie zur Schilddrüsenresektion [21] 
wiesen 19 der 160 Patienten Komplikationen auf. 
 
Diskussion 
Die Qualitätsbewertung der einzelnen Studien erfolgte anhand der ISPOR 
Task Force Checkliste für die Qualitätsbewertung von retrospektiven Daten-
bank-Studien [30]. Hinsichtlich der Wirksamkeit und Sicherheit von MM 
ist die Qualität der Evidenzbasis sehr gering. Die Hauptgründe dafür sind 
das retrospektive Design aller Studien [21-28], die fehlende Rechtfertigung 
für die Verwendung dieses Studiendesigns [21, 22, 25-27] und der fehlende a 
priori festgelegte Plan der Datenauswertung [21-28]. Weitere Gründe sind un-
klare Auswahl- bzw. Zulassungskriterien [21-23, 27, 28], fehlende Rechtfer-
tigung für die verwendeten statistischen Modelle [21-23, 25-28], mangelnde 
Interpretation der statistischen Ergebnisse in Bezug auf ihre klinische oder 
ökonomische Evidenz [22, 23, 25-28] und begrenzte Generalisierbarkeit des 
retrospektiven Studiendesigns [21, 22, 25-27]. 
Aufgrund dieser Evidenzlücken ist die Relevanz der aktuellen Evidenzbasis 
für die relative Wirksamkeitsbewertung von MM fraglich. Retrospektive Da-
tenbankanalysen erfüllen nicht die Anforderungen der evidenzbasierten Me-
dizin, da sie für ein breites Spektrum an Verzerrungen anfällig sind. Aus die-
sem Grund sind ihre Schlussfolgerungen nur teilweise anwendbar. Zu ihren 
Gunsten fallen die relativ robuste Evidenz aus dem stationären Bereich, die 
relativ hohe Zahl der einbezogenen PatientInnen in den identifizierten und 
eingeschlossenen Tageschirurgie-Studien und Studien, die keinen signifikan-
ten Unterschied in den Ergebnissen zwischen den Settings belegen, aus [3]. 
Demgegenüber stehen die schlechte interne und externe Validität der vorlie-
genden Evidenzbasis und die kritischen Überlegungen zu MM im Allgemei-
nen. Die Generalisierbarkeit der Daten ist kritisch zu hinterfragen, da alle 
Studien (mit Ausnahme von [27]) in den USA durchgeführt wurden, wo die 
Definition von Tages- und ambulanter Chirurgie variieren kann [20]. 
Bei der Durchführung der Analyse von Mengen-Ergebnis-Beziehungen (MEB) 
sollte darauf geachtet werden, nicht monokausale Erklärungsansätze anzu-
wenden oder nicht in die umgekehrte Kausalitätsfalle zu geraten, wenn man 
Verbindungen zwischen zwei oder mehreren Variablen herstellt. Eine beo-
bachtete Korrelation deutet nicht unbedingt auf einen kausalen Zusammen-
hang hin – Korrelation ≠ Kausalität. Vor diesem Hintergrund ist es wichtig, 
die verschiedenen Erklärungsansätze zu berücksichtigen, um die Komplexi-
tät der MEB und die daraus abgeleiteten Strategien zur Geltung zu bringen. 
Die beiden Ansätze – Übung macht den Meister und selektive Überweisung 
– implizieren deutlich unterschiedliche politische Strategien und Vorgehens-
weisen [8]. Während die Übung macht den Meister-Hypothese Argumente für 
die Implementierung eines (regulatorischen) Rahmens in Form von MM lie-
fert, würde die Hypothese der selektiven Überweisung indirekt an die Versor-
gungsforschung appellieren, zu verstehen, warum Phänomene wie Leistungs-
zentralisierung in Form von Akkumulation von Behandlungsfällen einiger 
weniger Krankenhäuser überhaupt auftreten. 
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Im Hinblick auf die Limitationen der vorliegenden systematischen Über-
sichtsarbeit fanden wir nur MEB-Daten zu acht Interventionen. Dies stellt 
jedoch keine repräsentative Stichprobe aller für eine tageschirurgischen in 
Frage kommenden Interventionen dar. Darüber hinaus wurden die folgenden 
Studien zur Arthroskopie, Meniskusrekonstruktion und Koloskopie [31-33] 
von der Analyse ausgeschlossen, obwohl sie die Einschlusskriterien erfüllten. 
Der Grund dafür war, dass sie in einer zusätzlichen Suche in der Endphase 
des Berichts gefunden wurden, als der Einschluss nicht mehr realisierbar 
war. Ein weiterer Grund, sie nicht einzubeziehen, war ihr erwarteter gerin-
ger Grenznutzen, da die Qualität aller Studien aufgrund ihres retrospektiven 
Studiendesigns gering war. 
 
Zusammenfassung 
Die Notwendigkeit einer Verlagerung von chirurgischen Eingriffen vom sta-
tionären in den ambulanten bzw. tageschirurgischen Bereich wird in der in-
ternationalen Literatur befürwortet. Da die MEB einen gewissen Stellenwert 
im stationären Bereich hat, wurde die Rolle von MM bei tageschirurgischen 
Interventionen in diesem Bericht untersucht. Neben der Theorie der MM 
wollten wir die Daten über internationale Variationen und die aktuelle Nut-
zung von MM mit einem besonderen Fokus auf den deutschen Kontext lie-
fern. Die Theorie der MM ist teilweise umstritten und auch die Ergebnisse 
unserer systematischen Übersichtsarbeit können keine eindeutigen MM-
Schwellenwerte bieten. Dieser vorliegende Bericht liefert jedoch einige Be-
lege zu Gunsten von MM, obwohl er auf retrospektiven Datenanalysen mit 
geringer Qualität basiert. Die geringe Qualität der gefundenen retrospekti-
ven Evidenz belegt weder die klare Präsenz einer MEB noch irgendwelche 
klaren MM. Zwei von acht Studien gaben keinen Hinweis auf eine MEB. 
Vor diesem Hintergrund empfehlen wir, dass die Anwendung von MM gut 
konzipiert und bis zum Ende gedacht werden sollte. Da die Herstellung ei-
ner MEB und damit auch eine Herleitung von MM möglich ist, sollten wei-
tere qualitätsgesicherte, prospektiv kontrollierte Studien im tageschirurgi-
schen Setting durchgeführt werden. Zudem sollten bei einer Entscheidung 
über Qualitätsverbesserungen andere Qualitätssicherungsmaßnahmen – wie 






Stichprobe von Studien 
und ausgeschlossene 
Evidenz, die potenziell 
relevant sein könnte 




MM im internationalen 
Kontext – besonderer 
Fokus auf Deutschland 
 
einige Hinweise  
zu Gunsten der MEB  
in der Tageschirurgie, 







 LBI-HTA | 2019 21 
1 Background 
The challenge of providing comprehensive health care of high quality that is 
available to all is shared by universal coverage health care systems of today 
[1]. Focusing on the setting of day surgery, one of the quality assurance mech-
anisms is minimum volume standards (MVSs). MVSs in day surgery are the 
topic of this report. 
Numerous research in the past has investigated the link between the quanti-
ty of conducted surgeries and its quality. This strand of research dates back 
up until the 1970’s [39]. One of the first research groups explicitly analysing 
the volume-outcome relationship (VOR) were Luft et al. in 1979 with their 
study on the empirical relation between surgical volume and mortality [6]. 
Since then, many studies – mostly retrospective – have been focusing on a set 
of interventions or on particular surgical interventions such as coronary-ar-
tery bypass grafting, esophagectomy, elective repair of abdominal aortic an-
eurysm, and cancer surgery [40-43]. Also systematic reviews for the previous 
mentioned interventions and even systematic reviews of systematic reviews 
have been conducted to verify the connection between surgical volume and 
outcome [44-46]. The majority of research observes a positive association in 
terms of statistical correlation between volume and outcome and infers a caus-
al inverse link between volume and outcome. This means the interpretation 
that with increasing surgical volume, health-related outcome measures such 
as mortality or further non-health related outcomes such as hospital readmis-
sion improve. 
The past findings in the literature and the need for steady improvement of 
the health care system and its provided services with regard to quality, safe-
ty, and efficiency lead to a debate about quantitative minimum requirements 
as a quality assurance criterion. As a result, governmental bodies such as the 
Federal Joint Committee (Gemeinsamer Bundesausschuss) and the Federal 
Association of Social Health Insurance Physician (Kassenärztliche Bundes-
vereinigung) in Germany, private organisations in the health system such as 
the Leapfrog Group in the USA, expert societies or single experts have pro-
moted (and still promote) the implementation of MVSs. As a result, MVSs 
with specific thresholds have been already implemented for elective surgeries 
in some countries, either in form of a regulative framework or suggested by 
respective expert societies [10]. 
The majority of the studies analysing the VOR and already implemented MVS 
frameworks have a common denominator. They are all primarily concerned 
with complex and high-risk surgeries mainly conducted in the inpatient set-
ting. The same denominator is also applied not only to the VOR, but also to 
the specific topic of MVSs. Hence, it seems that the relationship is generally 
accepted for complex and high-risk procedures and supported in the form of 
a statistical correlation – although the majority of the studies are lacking me-
thodical rigour. The quality enhancing effect of MVSs, however, especially for 
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Also in Austria, inpatient services including day surgeries are gradually shift-
ed to the ambulatory setting. The planned shift specified in the course of the 
Target-Based Health Governance (Zielsteuerung-Gesundheit), the federal con-
tract on Target-Based Governance (Vertrag zur Zielsteuerung-Gesundheit auf 
Bundesebene – B-ZS) and the underlying regulations makes it imperative to 
define comprehensive, standardised, and applicable quality standards across 
sectors. Especially, the complexity and the fragmentation of the health care 
system, which includes different legal responsibilities within the ambulatory 
care setting and the mixed financing structure, pose a challenge that needs to 
be taken into account when implementing quality standards for day surgery 
across different sectors. MVSs in the ambulatory surgical setting may consti-
tute a supplement to commonly applied and currently developed quality stand-
ards. 
The aim of this report was to address the question of quality assurance in day 
surgery, with a particular focus on MVSs. We thus aimed to analyse the day 
surgery setting, scrutinise the fundamentals of the VOR and MVSs, map the 
current practice of using MVSs, and provide the evidence on the effectiveness 
and safety of MVSs in specific day surgery interventions. Thus, in terms of 
structure of this report, we first set the background of day surgery, analyse the 
role of MVSs, and present the case of Germany where MVSs in day surgery 
are in place. Then, we present the data from our systematic review on MVSs 
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2 Methods 
2.1 Research questions 
Day surgery setting 
Element ID Research question 
A0002 What is day surgery? 
A0003 What are the interventions suitable for the day surgery setting? 
A0001 What are the particular interventions at stake in the current assessment? 
B0008 What kind of special premises are needed for conducting day surgery inteventions? 
B0009 What equipment and supplies are needed for conducting day surgery interventions? 
A0007  What is the target population for day surgery? 
A0023 How many people belong to the target population? 
A0006 What are the consequences of implementing day surgery? 
A0025 How is day surgery managed according to GL and in practice? 
 
Description of minimum volume standards and current use 
Element ID Research question 
B0001 What are minimum volume standards? 
B0018 Are thresholds and administrative reference values clearly established? 
A0012 What kind of variations in use are there across countries 
B0002 What are the claimed benefits and consequences 
 
Organisational aspects and policy implications in the Austrian context 
Element ID Research question 
B0012 What kinds of requirements in terms of quality assurance processes are needed  
for implementation? 
 
Clinical Effectiveness and Safety 
Element ID Research question 
D0001 What is the expected beneficial effect of MVSs on mortality? 
D0005 How does MVSs affect symptoms and findings of the disease or health condition? 
D0006 How does MVSs affect progression (or recurrence) of the disease or health condition? 
D0010 How does MVSs modify the need for hospitalisation? 
D0013 What is the effect of MVSs on disease-specific quality of life? 
D0017 Was the use of MVSs worthwhile? 
C0008 Are interventions with required surgeon/hospital MVSs safer than intervention without MVS? 
C0005 What are the susceptible patient groups that are more likely to be harmed  
through the use of MVSs? 
B0010 What kind of data/records and/or registry is needed to monitor the application of MVSs? 
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2.2 PICO question for clinical effectiveness 
and safety of minimum volume standards 
Do minimum volume standards in comparison to no minimum volume stand-
ards in the day surgery setting lead to better efficacy and safety outcomes? 
 
 
2.3 Inclusion criteria 
Inclusion criteria for relevant studies are summarised  
in Table 2-1. 
Table 2-1: Inclusion criteria 
Population Patients suitable for day surgery, for example:  
 according to anesthesia risk classes (ÖGARI), 
 according to the type of anesthetic options (local, mask), 
 according to ASA classification or general illness/condition.  
The appropriate patients are identified in the literature analysis  
for the specific interventions/indications found. 
Key words: day surgery, same day surgery, ambulatory surgery,  
outpatient surgery, day-care hospital, day only, zero-day hospital stays 
Intervention Identified surgical interventions from the international literature in the day 
surgery setting that implement minimum volume standards. 
Control The same or comparable surgical interventions in the day surgery setting 
without minimum volume standards implemented.  
Outcomes Depending on the identified indications/interventions, general health-relevant 
results such as morbidity, mortality, functional outcomes such as functionality 
in everyday life or at the workplace, quality of life or satisfaction are taken 
into account. In addition, results are specifically considered for outpatient 
interventions such as frequency of hospital infections and venous thrombosis 
embolisms, etc. 
Setting Day surgery/outpatient care/day clinic/zero-day stays/same-day surgery 
Study design No limitation 
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2.4 Sources 
Day surgery setting 
 Exploratory web-based literature search 
 Hand search in the UpToDate, POP, AdHopHTA and  
CRD databases for Health Technology Assessments 
 Background publications identified in database search: see section 2.7 
Description of minimum volume standards and current use 
 Background publications identified in database search: see section 2.7 
 Exploratory web-based literature search in combination with Google, 
Google Scholar, and PubMed 
 Hand search in websites of governmental or public bodies, (surgical) 
expert societies, non-departmental public bodies, and other stakehold-
ers in various health systems (only sources in German/English language) 
 
 
2.5 Systematic literature search  
for clinical effectiveness and safety 
For the domains clinical effectiveness and safety, the systematic literature 
search was conducted on the 12th of July 2019 in the following databases:  
 Medline via Ovid 
 Embase  
 The Cochrane Library 
 CRD (DARE, NHS-EED, HTA) 
 Livivo 
The systematic search was limited to the years 2000 to 2019 and to articles 
published in English or German. After deduplication, overall 538 citations 
were included. The specific search strategy employed can be found in the Ap-
pendix. 
By hand-search, an additional 57 citations were found, resulting in overall 
595 hits.  
Assessment elements from the EUnetHTA Core Model® for screening tech-
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2.6 Literature search and methods used for 
the section on minimum volume standards 
Complementary literature search for the contextualisation of the present anal-
ysis and in particular for the domain minimum volume standards was carried 
out using an exploratory search in: 
 Google,  
 Google Scholar, and 
 PubMed 
In addition, a hand search in websites of the following entities  
was conducted: 
 Governmental or public bodies (e.g. NHS, G-BA, KBV, KV, etc.) 
 Social health insurance funds/institutions  
(Allgemeine Ortskrankenkasse in Germany etc.) 
 Surgical expert societies (e.g. IAAS, Bundesärztekammer in 
Deutschland, Bundesverband für ambulantes Operieren e.V. etc.) 
 Non-departmental public bodies  
(e.g. NICE, IQwiG, GÖG GmbH, NIH, etc.) and, 
 other stakeholders in various health systems  
(Deutsche Krankenhausgesellschaft in Germany). 
The search was limited to articles published in English or German and was 
conducted over the period of report writing. The specific search strategy em-
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2.7 Flow chart of study selection 
for effectiveness and safety of MVSs 
Overall 595 hits were identified. The references were screened by two in-
dependent researchers (MS, CS). All cases of disagreement were resolved 
through discussion. The selection process is displayed in Figure 2-1. 
 
Figure 2-1: Flow chart of study selection (PRISMA Flow Diagram) 
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2.8 Analysis and Synthesis 
For the systematic literature search on effectiveness and safety, the data re-
trieved from the selected studies were systematically extracted into data-ex-
traction-tables (see Appendix Table 13-1 and Table 13-2). No further data pro-
cessing (e.g. indirect comparison) was applied. Two independent researchers 
(MS, CS) systematically assessed the quality of evidence using the checklist 
presented in the Appendix (Table 13-3). Due to the retrospective study design, 
data on each selected outcome category were not synthesised across studies 
according to Grading of Recommendations Assessment, Development and 
Evaluation (GRADE). 
For the analysis of minimum volume standards, the information retrieved 
form the identified literature was used in conjunction with adjusted assess-
ment elements from the EUnetHTA Core Model® 3.0 to structure the chap-
ter on MVSs. According to the identified literature, the hand, and explorato-
ry search, no country (except for Germany) seems to have specific threshold 
values for day or ambulatory surgery in force. Therefore, MVSs in ambulato-
ry care in Germany is discussed in detail in chapter 7. The data for ambula-
tory surgeries for which minimum quantities and frequency regulations are 
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3 Day surgery setting 
3.1 Overview of the day surgery setting 
3.1.1 Austrian context 
In Austria, the health care system is complex and fragmented. Responsibili-
ties are divided between the federal government and the federal states (Län-
der). In addition, tasks are delegated to self-governing bodies such as the so-
cial insurance and professional associations of health care providers. Due to 
the fragmentation, day surgery is regulated differently depending on the set-
ting and the corresponding legal authority responsible for the premises where 
it takes place. It can take place in the hospital setting (intramural) in the form 
of a 0-day admission (0-Tagesaufenthalt) or day care (tagesklinische Versor-
gung), whereby under the latter regulation, only those types of surgeries are 
reimbursed that are listed in the ambulatory Austrian DRG-System (LKF 
ambulant). In addition, it can take place in the extramural setting (niederge-
lassener Bereich) on a (contracted) private practice basis or in outpatient clin-
ics (selbstständige Ambulatorien) [47, 48]. Both sectors are characterised by 
different regulations and responsibilities for reimbursement. Hospital-based 
day surgeries are reimbursed according to the DRG-based hospital financing 
system (Leistungsorientierte Krankenanstaltenfinanzierung), whereas day sur-
geries in extramural care (niedergelassener Bereich) are reimbursed accord-
ing to tariffs that result from negotiations between the self-governing bodies 
of social insurance funds and providers represented by the chamber of phy-
sicians [47]. 
In the context of the target-based Health Governance (Zielsteuerung-Gesund-
heit), the underlying regulations, and the federal contract on Target-Based 
Governance (Vertrag zur Zielsteuerung-Gesundheit auf Bundesebene – B-
ZV), one central objective is to relieve the burden on the fully inpatient sec-
tor in acute hospitals (stationärer Sektor) by shifting services to the day care 
(tagesklinische Versorgung im Krankenhaus) or outpatient sector (extramu-
ral). Hence, day surgeries in hospital day clinics, the private sector, and in-
dependent outpatient clinics are expected to be on the rise [49-51]. Because 
of the different responsibilities, no clear cut definition on day surgery across 
settings is available for Austria compared to other health systems. 
 
3.1.2 General definition 
The International Association for Ambulatory Surgery (IAAS) defines day sur-
gery as a practice where patients are admitted, operated on, and discharged 
during the time frame of one working day (six to eight hours), with no over-
night stay [2]. The current definition from B-ZV conveys a similar meaning 
as the IAAS definition, however, it does not explicitly mention the length of 
a working day and it mentions the hospital setting. It states that day surgery 
refers to the hospital care for patients who receive an intervention from the 
catalogue of daily reimbursed interventions (according to the Austrian DRG 
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The EU observatory as well as the British Association for Day Surgery (BADS) 
further add that “true” day surgery includes planned non-emergency surgi-
cal procedures on carefully-selected and prepared patients that are intended 
to be treated in the day surgery setting [3, 4]. Because some procedures may 
require longer recovery/observation, in order to keep them as day surgeries, 
they have to be performed in the morning sessions [4]. The US ambulatory 
care setting shares the definition of IAAS [52], yet at times, the US’ use of 
the term day surgery includes 23 hours stay surgery, which in the EU is seen 
as an inpatient surgery with a one day length of stay (LOS). 
Alternative terms conveying the same meaning in different contexts are same 
day surgery, ambulatory surgery, outpatient surgery, day-care hospital, day only, or 
zero day hospital stay. For a complete list of terms used throughout the assess-
ment, please see Table 3-1. 
Table 3-1: Internationally agreed terminology, abbreviations and definitions as proposed by the IAAS [3] 
Terminology  Synonyms and definitions 
Day surgery Ambulatory surgery, same-day surgery, day only 
Day surgery 
center 
Ambulatory surgery center, day-surgery unit, ambulatory surgery unit, day clinic. A center 
or facility designed for the optimum management of an ambulatory surgery patient. 
Extended 
recovery 
23 hours, overnight stay, single night. Treatments requiring an overnight stay  
before discharge. 
Short stay Treatments requiring 24–72 hours in hospital before discharge. 
Outpatient A patient treated at a hospital who is not admitted for a stay of 24 hours or more.  




An operation or procedure carried out in a medical practitioner’s professional premises, 




An operation or procedure which is not outpatient- or office-based, where the patient  
is discharged on the same working day. 
 
3.1.3 Reasons of implementing day surgery 
Reasons for the shift from inpatient surgery to the day surgery context are 
manifold: organisational, ethical, economic, and medical. The aim is to im-
prove the pathway of care, while alleviating the distributive justice mecha-
nism and thus saving economic resources that can be allocated elsewhere. 
Day surgeries allow patients to choose their own surrounding to convalesce 
and they are associated with shorter waiting times and lower risks of surgery 
cancellation [20]. Also, day surgeries claim to reduce the rates of hospital-
acquired infection and venous thromboembolism [20].  
Furthermore, the consequences of shifting to day surgery seem to be a win-
win situation for all parties involved [20]. Omitting overnight and weekend 
stays can be a benefit both for the patient as well as for the medical team that 
does not have to stay at work over those times. This, in turn, saves the re-
sources to the payers, potentially making the surgical interventions less ex-
pensive overall. In a report published by the NHS in the United Kingdom in 
1989, costs of day surgery were estimated to be significantly lower compared 
to in-patient treatment [53]. In 2015, the Kings Fund verified the initial esti-
mates stating that increases in day surgery over the period from 1998 to 2013 
have generated savings of around £ 2 billion (€ 2.32 billion) [54]. 
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From a scientific perspective, however, further surgery specific economic eval-
uations are necessary for a more concrete assessment of the economic di-
mension of day surgery as the 2012 report from LBI-HTA did not identify 
any meaningful cost comparisons for 11 procedures between day surgery and 
inpatient surgery setting [53].  
Further patient-relevant consequences of day surgery are increase of control 
over patients’ own time and health. Being called to come right before the in-
tervention and then being followed by a telephone call after the intervention 
allows the patients to be more in charge [20]. Day surgery also potentially 
reduces the stigma that is associated with hospital admission as the patients 
return home within one working day. 
 
 
3.2 Interventions and target population  
of the current assessment 
3.2.1 Interventions in general 
The past 30 years have seen a shift from inpatient pathways to day surgeries 
that are performed by both public as well as private entities that, thanks to 
advances in anesthesia and surgical techniques [20], treat an increasing num-
ber of patients without the need of hospital admission.  
The list of interventions suitable for day surgery varies from one country to 
another and, along with the technological developments, it is still expanding. 
In 1990 in the UK, a list of 32 procedures was included in the “basket” of in-
terventions suitable for day surgery. In 2006, the British Association for Day 
Surgery directory of procedures published its 4th edition with 200 procedures 
across all surgical specialties [20]. In 2019, the 6th edition of the BADS Di-
rectory of Procedures includes more than 300 procedures [4]. The NHS In-
stitute for Innovation and Improvement even advocates the eventual shift of 
all elective surgery to the day surgery context [20]. For a detailed historical de-
velopment of day surgery, see the LBI-HTA report on “Tageschirurgie” from 
2012 [55]. 
As for January 2019, the Austrian model of reimbursed ambulatory medical 
services (Leistungskatalog BMASGK 2019 – Codierung ambulant) contained 
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3.2.2 Interventions and target population at stake 
in the current assessment 
The interventions at stake in the current assessment were selected based up-
on the systematic literature search. All those interventions that reported in-
formation of the volume-outcome relationship in the day surgery setting were 
included. 
This list of interventions is the following: 
 thyroid surgery (thyroidectomy), 
 cataract surgery, 
 primary hip arthroscopy, 
 open carpal tunnel release, 
 rotator cuff repair, 
 anterior cruciate ligament reconstruction, and 
 meniscectomy. 
In addition, the target population and the volume of the target population 
will be addressed in the course of analysing each specific indication. 
 
Thyroid surgery (thyroidectomy) 
Thyroidectomy is the removal of part or all of the thyroid gland. While thy-
roid surgery used to be reserved for cases of goiter with mortality rate of 40% 
or higher in the past, today, thyroid surgery has evolved into a common pro-
cedure performed on selected patients also in the day surgery setting [21]. 
Most frequent reasons why patients may be admitted for overnight observa-
tion are pain management, hypocalcemia, or hematoma formation monitor-
ing [57].  
Thyroidectomy is the most frequently used thyroid surgery [58] and it targets 
a number of benign as well as malignant conditions including [57]: 
 thyroid nodules, 
 hyperthyroidism, 
 obstructive or substernal goiter, 
 differentiated (papillary or follicular) thyroid cancer, 
 medullary thyroid cancer, 
 anaplastic thyroid cancer, 
 primary thyroid lymphoma (surgery for obtaining tissue biopsy), and 
 metastases to the thyroid. 
Thyroid nodules are solid or fluid-filled lumps that form within the thyroid. 
The great majority of thyroid nodules are not serious and do not cause symp-
toms [59] and so thyroidectomy is a procedure of choice for those patients 
with thyroid nodules, who have an increased chance of the nodules being can-
cerous [60].  
Hyperthyroidism is, for the most part, caused by Graves disease – caused by 
autoantibodies to the thyrotropin receptor [61]. Other causes of hyperthyroid-
ism include toxic multinodular goiter, toxic single adenoma, and thyroiditis 
[61]. For most instances of hyperthyroidism, thyroidectomy is the treatment 
of choice [61].  
Interventionen im 
vorliegenden Bericht 






















häufige Gründe für 




Thyreoidektomie ist die 
häufigste Schilddrüsen-




Thyreoidektomie ist  
v. a. für Risikogruppen 
von Belang 
Basedowkrankheit  
meist als Ursache für 
eine Hyperthyreose 
Day surgery setting 
LBI-HTA | 2019 33 
Goiter refers to abnormal growth of the thyroid gland. In the cases of obstruc-
tive or substernal goiter, thyroidectomy may be in place due to compressive 
symptoms, potential airway compromise, and the possibility of an association 
with thyroid malignancy [62]. 
Thyroid cancer is the most common endocrine malignancy [63] and the most 
common indication for thyroidectomy [58]. Reasons for its increase in in-
cidence is unclear, yet one explanation is overdiagnosis caused by the wide-
spread use of radiology tests detecting small non-palpable thyroid cancers 
[63]. The incidence of thyroid cancer in Austria between years 2014 to 2016 
was 837 new cases annually [64]. It was two to three fold more common in fe-
males than males [64], which is aligned with the international statistics [63]. 
Even though the peak incidence of thyroid cancer diagnosis is 45 to 49 years 
in women and 65 to 69 years in men, it nonetheless affects young people – 
accounting for approximately 10% of malignancies diagnosed in persons 
aged 15 to 29 years [63].  
However, the most prevalent type of thyroid cancer, papillary carcinoma, is 
a peculiar case. The proliferation rate of papillary microcarcinoma was neg-
atively correlated with age and surgery to remove it did not contribute to re-
duced mortality from thyroid cancer [65]. This finding suggests the existence 
of truly malignant self-limiting cancer that does not always progress to the 
lethal stage [65]. The majority of lethal thyroid cancers appear suddenly af-
ter middle age [65]. 
 
Cataract surgery (phacoemulsification) 
Cataract surgery is a procedure to remove the lens of the eye and, in most cas-
es, replace it with an artificial lens. It is usually performed in the day surgery 
setting under local anesthesia supplied by block, or by local infusion [66]. 
Cataract surgery is a treatment for the condition of cataract, which is an opac-
ity of the lens of the eye that may cause blurred or distorted vision, glare prob-
lems, or, in very advanced cases, blindness [66]. Cataracts may be seen as 
normal parts of ageing, however, excessive exposure to sunlight, poor nutri-
tion, metabolic insults, trauma, and medications such as cortisone may speed 
their development [66]. Because cataracts are an important cause of blind-
ness, they carry a high burden of disease. The proportion of blindness due to 
cataract ranges from 12.7% in North America to 42% in Southeast Asia [66]. 
In 2016 in Austria, there were 110,125 cataract surgeries conducted in both 
inpatient and day surgery centers [67]. At the backdrop of the paucity of pre-
ventive approaches and nonsurgical therapy, surgery is the treatment of choice 
[66]. 
The two surgical techniques that are most commonly used for cataract ex-
traction are phacoemulsification and standard extracapsular cataract extrac-
tion [66]: 
 Phacoemulsification, also called small incision surgery, is the most 
common cataract removal technique in high-resource countries. It is 
performed through a small incision (one to three millimeters) that re-
quires one suture at most. A probe containing a needle that vibrates 
with ultrasonic energy is used to fragment the hard central part of the 
lens. The softer cortex is then aspirated and the lens capsule is left 
behind. A foldable plastic or silicone lens is then put in place instead. 
In advanced cataracts when the lens nucleus is very hard, phacoemul-
sification may not be feasible. 
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 Standard extracapsular cataract extraction typically involves removal 
of the lens nucleus in one piece. The lens cortex is aspirated from the 
eye and the lens capsule is left behind to support an intraocular lens. 
A rigid plastic lens is inserted through the same incision and placed 
on or in the capsule behind the iris. 
Cataract surgery is a low risk procedure, however, because it is typically per-
formed in older adults with multiple comorbidities, its risk may be increased 
[66]. The most frequent complications include: toxic anterior segment syn-
drome, clinically apparent cystoid macular edema, retinal detachment, and 
the risk of macular degeneration [66]. 
 
Hip arthroscopy 
Hip arthroscopy is a minimally invasive surgical procedure used for diagno-
sis as well as treatment and it is commonly performed in the day surgery set-
ting [68]. Requiring only two to three incisions, it allows doctors to view the 
hip joint without having to use the traditional open techniques. Conditions, 
for which hip arthroscopy is used are the following [69]: 
 removal of symptomatic loose bodies, 
 labral lesions, 
 femoral acetabular impingement, 
 acute articular injury, 
 microfracture of select grade IV articular cartilage lesions, 
 traumatic rupture of the ligamentum teres, 
 dysplasia, 
 hip instability, 
 arthroscopic synovectomy of the hip, 
 debridement, 
 adhesive capsulitis of the hip, 
 osteonecrosis, 
 end-stage avascular necrosis, and 
 hip joint sepsis. 
The primary causes of hip conditions that lead to hip arthroscopy are age-
ing, sports injuries, obesity, and bone and joint disorders like rheumatoid ar-
thritis or hemochromatosis [70]. Despite improvements in equipment and 
training, arthroscopy remains to be a challenging procedure with revision sur-
gery rates of anywhere from 6.3% to 16.9% [28]. Complications associated 
with hip arthroscopy include traction-related nerve injuries, fluid extravasa-
tion, infection, osteonecrosis, and heterotopic ossification [71].  
Hip arthroplasty, or total hip replacement, is the surgical intervention of 
choice in cases when hip arthroscopy does not bring the desired effect [72]. 
Hip arthroplasty refers to the procedure where the damaged bone and carti-
lage are removed and replaced with prosthetic components [72]. In 2015, there 
were 271.1 hip arthroplasties per 100,000 population in Austria, making it 
the third country among OECD with the most frequent use of hip arthroplas-
ty (after Switzerland and Germany) [73]. 
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Open carpal tunnel release 
Carpal tunnel release surgery (or decompression surgery) is a surgical treat-
ment of the carpal tunnel syndrome (CTS) that is commonly performed in 
the day surgery setting. CTS is a condition that occurs when one or more ma-
jor nerves on the hand are squeezed or compressed as they travel through the 
wrist and so release surgery is recommended for most patients with severe 
CTS [74]. Those patients who lack evidence of significant axonal loss or de-
nervation can be treated initially with nonsurgical measures such as noctur-
nal wrist splinting in the neutral position or a glucocorticoid injection [74]. 
CTS refers to the complex of symptoms and signs brought on by compression 
of the median nerve as it travels through the carpal tunnel. Patients common-
ly experience pain, paresthesia, and weakness in the median nerve distri-
bution. CTS is the most frequent compressive focal mononeuropathy seen in 
clinical practice [74]. Carpal tunnel release is hence the most frequently per-
formed surgical procedure of the hand and wrist with estimates of 400,000 to 
600,000 carpal tunnel releases performed annually in the United States [27]. 
The estimated prevalence of CTS in the general population is one to five per-
cent. CTS is more frequent in women, with a female-to-male ratio of approx-
imately three to one [75]. Risk factors for CTS include obesity, female gen-
der, coexisting conditions (such as diabetes, pregnancy, rheumatoid arthri-
tis, hypothyroidism, connective tissue diseases, preexisting median mononeu-
ropathy), genetic predisposition, and aromatase inhibitor use [75]. The role 
of repetitive hand/wrist use and workplace factors in the development of CTS 
is controversial [75]. 
Carpal tunnel release surgery can be done either as an open surgery – per-
formed through a standard incision or a limited incision, or as an endoscop-
ic surgery – performed through a single or double portal [76]. Most frequent 
complications include the incomplete release of the transverse carpal ligament 
and the development of complex regional pain syndrome [76]. Majority of 
complications in relation to carpal tunnel release are, however, related to the 
surgery itself, with the rate of only one to two percent of long term complica-
tions when performed by experienced surgeons [76]. 
 
Rotator cuff repair 
Rotator cuff repair is a surgical treatment of rotator cuff disorders (rotator 
cuff tendinitis/tendinopathy – inflamed or irritated shoulder tendons) that 
is commonly treated in the day surgery setting [25]. It is a line of treatment 
that is recommended to patients after less invasive treatments fail (rest, non-
steroidal anti-inflammatory drugs (NSAIDs), adjunct therapies such as elec-
trical stimulation/therapeutic ultrasound/laser, physical therapy, glucocor-
ticoids, or topical glyceryl trinitrate therapy) [77]. In situations of acute, full 
thickness traumatic tear of an otherwise normal rotator cuff in a healthy in-
dividual, rotator cuff repair is recommended within six weeks of injury [78]. 
The prevalence of rotator cuff abnormalities increases with age and occupa-
tion type. Its prevalence in patients aged 20 years or younger is 9.7% as op-
posed to 62% in patients aged 80 years and older [79]. Furthermore, in work-
ing populations, the incidence of shoulder-related symptoms may be as high 
as 14-18% [77]. Rotator cuff disorders are a significant source of morbidity 
among manual laborers and those whose work involves a great deal of repeti-
tive motion [77]. 
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Hence, repetitive overhead activity, whether in sport or work, is a major risk 
factor for rotator cuff tendinopathy. Other risk factors include anatomic var-
iants that predispose to rotator cuff impingement, scapular instability or dys-
kinesis, older age, increased BMI, diabetes, and hyperlipidemia [77]. Any of 
the rotator cuff tendons may be involved, but the supraspinatus tendon is most 
frequently injured [77]. 
Concerning clinical examination, routine plain radiographs of the shoulder 
do not reveal signs of rotator cuff tendinopathy and are generally not indicat-
ed in patients suspected of such injuries. Musculoskeletal ultrasound is con-
sidered the gold standard for the initial evaluation of tendon disorders with 
additional ultrasound or magnetic resonance imaging (MRI) as the follow-
ing diagnostic steps [77]. 
The appropriate surgical intervention varies with the patient's age, comor-
bidities, level of activity, and the location and type of rotator cuff pathology. 
Three basic surgical interventions exist: debridement, acromioplasty with de-
bridement, and rotator cuff repair [77]. Rotator cuff repair can be performed 
either arthroscopically or in open (alternatively “mini-open”) surgery [78]. 
All three techniques aim at providing a secure repair of the rotator cuff ten-
don over a large tendon-bone contact area at the original cuff attachment site 
on the humerus [78]. Arthroscopic repair is the current procedure of choice 
for its benefits of limited invasiveness and the ability to see the entire joint 
including the rotator cuff [78]. Complication rates increase with the age of 
the target population and they include rerupture, deltoid detachment, infec-
tions, axillary nerve injury, glenohumeral joint stiffness, and postoperative 
pain [78]. Postoperative rehabilitation protocols depend upon the extent of 
the injury and repair. 
 
Anterior cruciate ligament reconstruction and meniscectomy 
Anterior cruciate ligament (ACL) reconstruction is a surgical treatment of ACL 
injuries (tears of sprains in the ACL in the knee) that is commonly treated 
in both inpatient as well as day surgery settings. ACL injuries are common 
in professional athletes and in the general population. Swedish estimates of 
soft tissue injuries suggest the incidence of 766 and 676 per 100,000 popula-
tion for males and females respectively [80].  
Acute management consists in rest, putting ice on the knee, compression of 
the injured knee, and elevation of the affected lower extremity [81]. NSAIDs 
provide effective short-term pain relief, but the appropriate treatment de-
pends upon the extent of injury, patient characteristics and activities, and 
available resources [81]. By and large, the patient population that tends to un-
dergo ACL reconstruction are those who participate in high-demand sports or 
occupations, or those who experience significant knee instability [81]. There 
are debates with respect to timing of the intervention as well as with respect 
to the type of graft to be used (autograft or allograft) [82]. The main diagnos-
tic instruments used are MRI and knee arthroscopy [81]. While short-term 
complications include infection and deficits to knee motion and strength, 
long-term complications include secondary ACL injury to either the involved 
or contralateral knee [83]. 
Meniscectomy is a surgical treatment of meniscal injuries that is commonly 
treated in both inpatient as well as day surgery settings. Meniscal injuries are 
common and can occur in isolation or in association with collateral or cruci-
ate ligament tears [84]. In the general US population, the incidence rate of 
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Acute management consists in rest, putting ice on the knee, walk with the 
crutches, and patellar restraining brace [84]. Whether to undergo meniscec-
tomy depends on a variety of factors such as frequency of symptoms, knee 
function, type of tear, or the likelihood that leaving meniscus unrepaired will 
lead to further damage of the articular cartilage [84]. Surgical treatment op-
tions include partial or total meniscectomy, and repair of the meniscal tear. 
Open or arthroscopic surgery can be performed always with the aim of retain-
ing as much of the functioning meniscus as possible [84]. The main diagnos-
tic instruments are plain radiographs, ultrasound, and MRI [84]. Intraopera-
tive complications of meniscectomy include neurovascular damages, instru-
ment breakage, and anesthesia complications. The most common postopera-
tive complications include deep vein thrombosis, infection, synovitis, arthro-
fibrosis, effusion, hemarthrosis, extra-articular edema, postoperative stiffness, 
and continuous pain [86]. 
 
 
3.3 Current management of day surgery 
According to the 2019 guideline from the Association of Anaesthetists (AA) 
and the BADS, patients eligible for day surgery interventions can be referred 
from outpatient clinics, emergency departments, or primary care [87]. It is 
thanks to the advances in surgical and anesthetic techniques that even pa-
tients with multiple comorbidities can be treated in the day care setting and 
hence AA and BADS suggest a paradigm shift towards day surgery – mean-
ing that if inpatient surgery is being considered, it is important to question 
whether any strategies could be employed to enable the patient to be treated 
as a day case [87]. 
Local agreements between surgeons and the anesthetic department are need-
ed for the appropriate patient selection and three main selection criteria need 
to be considered when assessing patients’ eligibility: social, medical, and sur-
gical [87]. 
 Social criteria include the need of a responsible adult to escort the pa-
tient home and the presence of a carer for a required number of hours 
postoperatively in patient’s home setting. The amount of time required 
depends on the invasiveness of the conducted intervention. 
 Medical criteria include patients’ fitness for the procedure and pres-
ence of a chronic disease. Morbidly obese patients or patients with ob-
structive sleep apnea may be also treated in the day surgery setting, 
however, appropriate measures need to be taken. Patients with unsta-
ble medical conditions in whom surgery is required before the patient’s 
condition can be optimised due to urgency may require inpatient ad-
mission. 
 Surgical criteria require that the intervention does not carry a signifi-
cant risk of serious postoperative complication that would need imme-
diate medical attention. Postoperative symptoms must be controlla-
ble and patients should be able to mobilise before discharge. If that is 
not possible, appropriate venous thromboembolism prophylaxis should 
be instituted and maintained. 
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Specific medical and anesthetic preparation is required for each day surgery 
intervention individually, yet general pre‐operative preparation includes [87]: 
 education of patients and carers on day surgery pathways, 
 communication of information on planned procedures and postopera-
tive care to help patients make informed decisions – important infor-
mation should come in writing, and 
 identification of medical risk factors, promotion of health  
and optimisation of patient’s condition. 
Treating a patient as a day case requires a well-organised day surgery unit 
that can communicate well with the patient before, during, as well as after 
the intervention. It is needed because patients should be admitted to the day 
surgery unit as close as possible to the time of their surgery and followed-up 
after the surgery once in their own home setting [87]. Patients should be pro-
vided with general, as well as procedure‐specific, information that should be 
given to them in advance of admission. Verbal comments should be reinforced 
with written material [87]. 
 
3.3.1 Premises, equipment, and supplies needed 
for day surgery interventions 
Day surgeries can be conducted in hospital outpatient departments, freestand-
ing ambulatory surgery centres, or in office-based surgeries [52]. Also, the 
same hospital beds used for inpatient surgeries can be used for day surgery 
procedures. The 2019 UK guideline suggests that day surgery works best when 
it is provided in a self‐contained unit that is functionally and structurally sep-
arate from inpatient wards and operating theatres. They suggest that each day 
surgery unit should have its own reception, consulting rooms, ward, theatres 
and recovery area, together with administrative facilities [87]. The operating 
theatre and first‐stage recovery areas should be equipped and staffed to the 
same standards as an inpatient facility, with the exception of the use of trol-
leys rather than beds [87]. Concerning equipment and supplies, the same is 
needed for conducting inpatient as well as day surgery interventions, except 
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4 Understanding the volume-outcome relationship 
Introspectively, practice makes perfect seems the most intuitive approach ex-
plaining the volume-outcome relationship (VOR). Practice makes perfect is a 
popular proverb used across a wide range of disciplines. The purported prac-
tice makes perfect hypothesis presumes that physicians, non-physician staff, or 
hospitals improve their (surgical) capabilities and outcomes with increasing 
volume of patients through a learning effect. The expected causality here is 
quite clear: quantity affects quality. This approach is mainly presumed as a 
working hypothesis to be tested in the literature [8-10, 42, 44, 88, 89] mainly 
initiated by the paper of Luft et al. [6]. Table 4-1 indicates the presumed di-
rection of causality for the practice makes perfect approach: a higher volume 
leads to a higher level of training and skill set of surgeons or other non-phy-
sician care team members. Also the managerial practices of the hospital or 
care unit are expected to be enhanced by an increasing volume. The expect-
ed result are higher-quality outcomes. 
Table 4-1: Causal direction in the volume-outcome relationship 
Hypothesis (Effect) 
Direction of Causality 
(independent variable → dependent variable) Decision-maker 
Practice makes 
perfect 
Volume → (Provider experience) → Outcome or Quality Health care planning 
and medical education 
Selective referral Outcome or (Provider) Quality → Volume Provider or Patient 
 
However, this quantity-quality relation is not the only approach utilised to 
link volume and outcome with each other. In the medical context, also the 
reverse hypothesis of the volume-outcome link – called selective referral – has 
been tested and proposed. The selective referral hypothesis assumes that high-
quality service providers are more likely to accumulate a large proportion of 
overall conducted services because patients are more likely to seek these pro-
viders in the first place (Table 4-1). In other words, volume depends on out-
come or the provider’s (initial) quality. Within this hypothesis, provider or 
patients (simultaneously) decide whether or not to undergo surgery. To fully 
understand the selection mechanism initiated by the provider or patient, it 
is essential to define the variable quality or outcome in a twofold nature. 
First, patients admitted for surgery are selected according to the service pro-
vider’ assessment of their need for surgery. Surgeries in different settings can 
have different priorities and different application procedures, e. g. emergen-
cy cases have a higher priority than routine or elective interventions. There-
fore, it is the hospitals or surgeons who decide whether or not a surgery is 
indicated – if possible in coordination with the patient (informed consent). 
The decision-making depends on expert knowledge, hospital and surgeon 
specialisation, and level of training or experience [90]. The volume of pa-
tients is not necessarily the defining factor. These factors can be summarised 
under the term provider quality or quality of making the right choice. Fur-
ther factors influencing the hospitals or surgeons’ decision whether or not a 
patient, de facto, receives a surgery are given by policy makers. These include 
factors such as regulations, reimbursement schemes, or other incentive mech-
anisms, yet they are thought to play a minor role [91]. 
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Second, in most of the non-emergency cases, the choice of surgery site can be 
made by the patient him- or herself and is even encouraged by health policy 
in some countries [92]. Proximity is certainly a major factor influencing the 
choice of the patient, but social and individual factors that determine the ac-
cessibility and affordability of health services have also an impact on the de-
cision-making process. These include general preferences, perceived quality, 
past experience, word-of-mouth recommendations, internet reviews, available 
information on the service provider, and health literacy of the patient [92-96]. 
Especially, non-classical (clinical) outcome measures that can be classified in 
the category patient-reported outcome measures (PROMs) or patient-report-
ed experience measures (PREMs) are of increasing importance [97, 98]. 
If it is expected that patients are more likely to seek high-quality providers 
or high-quality providers have a different referral or public advertising policy, 
then volume results from patients and providers’ preferences. Accumulated 
volume is then not the cause for quality, but quality is the cause for volume. 
Therefore, it is possible that different providers with similar quality standards 
(ceteris paribus) that provided services with high-quality outcome in the first 
place (regardless of their past volumes) accumulate significantly different vol-
umes [7]. Both hypotheses seem to be valid in the empirical literature [8]. 
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5 Description of minimum 
volume standards and current use 
5.1 General Characteristics 
On the basis of the previous available studies analysing the VOR, stakehold-
ers in the health care sector have promoted and demanded (and still promote/ 
demand) the implementation of a (regulatory) MVSs framework besides fur-
ther quality standards. MVSs should assure that surgeons or hospitals that 
comply with the minimum volume of surgeries provide a certain level of qual-
ity. In most of the cases, annual volumes per surgeon or hospital are consid-
ered in MVS frameworks. The definition of annual MVSs corresponds to the 
notion of minimum volumes as an instrument for ability maintenance guar-
anteed by the routine for surgeons and hospitals [9]. 
A possible consequence of not complying with these minimum requirements 
in regulatory MVS frameworks – but mostly rarely enforced – is that surger-
ies are not reimbursed anymore [10]. In other words, if a surgeon or hospital 
does not perform the specified number of surgeries, the particular surgical in-
tervention may no longer be performed. Certainly, consequences depend on 
who specifies and defines these minimum standards. There are different con-
sequences when expert societies provide only recommendations or exercise 
peer pressure compared to a legal basis with the possibility of enforcement 
of consequences. For example, in the Netherlands, there is no legal basis for 
MVSs, but MVSs in the inpatient setting are highly respected and valued due 
to the commitment by the professional associations. Adherence to quality 
standards is utilised for price negotiations between hospitals and the Dutch 
health care system. If targets are not met, then it is possible that this service 
is not reimbursed [10]. 
MVSs can be defined on various levels: 
 Surgeon/Surgical team 
 Hospital department/Hospital 
In most of the studies analysing the VOR, both surgeon and care unit volumes 
are used as the unit of analysis. But generally, individual surgeon volume is 
seen as the decisive factor. While surgeon volume seems more important for 
surgeries with a shorter length of stay and specific intraoperative abilities com-
pared to hospital volume, hospital volume appears more decisive for longer 
lengths of stay and intensive care [42, 44, 89]. 
The distinction between these various levels is not only important for the sake 
of ruling out any biases when analysing the VOR with the aim of providing 
solid evidence for decision-makers. A clear formulation of the unit in con-
sideration is also essential for compliance of MVSs. 
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5.2 Thresholds and administrative  
reference values 
The literature on the VOR provides no universally solid method to specify 
administrative MVS thresholds [13, 14]. Generally, modelling approaches on 
the basis of regression models seem to be most appropriate, but the choice of 
the appropriate model depends on the specific problem and the available da-
ta [15, 16]. Most of the studies implementing regression models neglect me-
thodical issues associated with the calculation of thresholds that consequent-
ly affect the reliability of the thresholds as discussed above [13, 17]. 
Only a high-quality body of evidence (prospective and controlled trials) that 
established a robust relationship between volume and outcome is recommend-
ed to consider when implementing administrative MVSs as a quality stand-
ard. A robust relationship can be understood as a number of studies clearly 
verifying a consistent statistical association between volume and outcome with 
substantial clinical relevance that is plausible, logical, and was verified on the 
basis of stringent statistical criteria. This notion is in accordance with the 
Nine Bradford-Hill criteria1 that are used when verifying potential causal re-
lationships and is also used by the National Cancer Policy Board in the US 
[7, 34]. Also in Germany, for MVSs to be in force, it is necessary that scienti-
fic studies suggest that there is a link between the amount and quality of 
treatment. “Common experience” does not serve as a sufficient basis. Further-
more, minimum volume standards are not allowed to be used for quantity con-
trol of provided services. This was also judicially confirmed by the German 
federal social court2. 
In the US, the Leapfrog Group – a national organisation formed and funded 
by the lobbying organisation Business Roundtable – set themselves the task 
to publicly report the quality and safety of health care services including 
MVSs for complex surgeries in order to allow people to make informed deci-
sions with regard to health care [99, 100]. Hospitals or surgeons are invited 
to participate on a voluntary basis. In the course of their reporting, the Leap-
frog group recommends MVSs per hospital and per surgeon for eight high-
risk procedures3 [101]. The suggested volumes, however, are also not without 
shortcomings [102]. For example, it is criticised that current esophagectomy 
volume may not predict optimal outcomes for all patients, especially at ex-
tremes of age and comorbidities [103]. 
 
                                                             
1 The criteria include: 1) strength of the association, 2) consistency of the observed 
association, 3) specificity of the association, 4) temporality of the association, 5) bi-
ological gradient or dose-response curve, 6) plausibility of the theory’s relationship 
with reality, 7) coherence with knowledge from other disciplines, 8) experiment with 
the association, and 9) analogy with other phenomena. 
2 Bundessozialgericht Urteil vom 29.11.2017, B 6 KA 32/16 R 
3 Bariatric surgery for weight loss, oesophageal resection for cancer, lung resection for 
cancer, pancreatic resection for cancer, rectal cancer surgery, carotid endarterectomy, 
open aortic procedures, mitral valve repair and replacement 
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Until 2019, the focus has been on reporting inpatient data, but as of April 
2019, the Leapfrog Group began collecting information on day surgery from 
321 ambulatory surgical centres (ASCs) and 1,141 hospital outpatient depart-
ments (HOPDs) that can freely participate in the survey. In future, the Leap-
frog Group plans to report performance measures including minimum vol-
umes for 10 specialities4 in the day surgery setting as well [104]. 
According to the identified literature, the hand and exploratory search, no 
country, except for Germany seems to have specific threshold values for day 
or ambulatory surgery in force [11, 12]. The case of MVSs in ambulatory care 
in Germany is discussed in detail in chapter 7. 
 
 
5.3 Variations in use of minimum 
volume standards across countries 
Various countries have already implemented MVSs in hospitals for selected 
complex and high-risk surgeries for quality and safety reasons. Among the 
countries that provide a MVSs framework in the inpatient setting are Ger-
many, Canada, the Netherlands, Switzerland and Austria [10]. 
We provide an overview of the current use of MVSs in five countries on the 
basis of the identified literature by Morche et al. [10]. The aim is to draw an 
analogy from inpatient high-risk surgeries to the day surgery setting in order 
to give some insights in general characteristics and in the organisational 
framework of MVSs (including reimbursement implications and consequen-
ces of non-compliance). The overview in Table 5-1 gives a description of the 
following aspects: 
 Countries with an established MVSs (regulatory) framework 
 Procedures affected by MVSs 
 Characteristics, requirements, and the evidence source of MVSs 
 Organisational and/or legal framework 
 Reimbursement implications and consequences of non-compliance 
 
 
                                                             
4 Gastroenterology, general surgery, ophthalmology, orthopaedic, otolaryngology, urol-
ogy, dermatology, neurological surgery, obstetrics and gynaecology, plastic and re-
constructive surgery 
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Table 5-1: International Variations and Current Use of MVSs 
Country Procedures Characteristics, Requirements and Evidence Organisational and legal framework Reimbursement and consequences 
Austria MVSs for 5 sets  
of procedures: 
 Pancreatic surgery 
 Esophageal surgery 
 Hepatic surgery 
 Bariatric surgery 
 Carotid endarterectomy 
 MVSs are implemented on the basis  
of studies with sufficient evidence, but 
sufficient evidence is not defined 
 Thresholds are established by expert 
consensus, representatives of federal 
states and the social insurance 
(Zielsteuerungspartner) 
 Sets of procedures and thresholds should 
be reevaluated annually according to 
international evidence 
 MVSs serve as a first response to the 
relationship between volume and 
outcome 
 Legal basis for MVSs is specified in the law 
(G-ZG) established in the course of the 
Austrian structural plan on health (ÖSG) 
in 2013 
 MVSs are used to ensure quality of care 
and as a basis for regional planning of 
health service provision 
 Qualified hospitals are determined by  
the authorised regional health fund 
(Landesgesundheitsfond) and private 
hospital financing funds (PRIKRAF) 
 MVSs refer to annual averages per hospital 
within three previous years 
 Consequences of non-compliance vary 
across states, but are not explicitily 
defined 
Germany MVSs for seven sets  
of procedures: 
 Pancreatic surgery 
 Esophageal surgery 
 Hepatic and Biliary Tract 
Surgery 
 Renal transplantation 
 Stem cell transplantation 
 Surgery of the knee 
 Neonatal procedures 
 Selection of procedures with MVSs  
are based on scientific data from 
international studies and reports from 
the IQWiG (Limited evidence to inform 
the selection of specific thresholds) 
 First evaluation of the impact of  
newly introdcued MVSs 3 years after 
implementation 
 MVSs and sets of procedures are defined 
by negotiations between care providers 
and insurance providers according to the 
legal framework 
 MVSs introduced by the Federal Joint 
Commitee (G-BA) on a legal mandate in 
the German Social Code Book V (SGB V)  
in 2004 
 Hospital operator must annually 
demonstrate to the associations of the 
health insurance funds that the required 
minimum quantity will probably be achieved 
in the next calendar year due to justified 
quantitative expectations based on the 
attainment in the preceding calendar year 
(prognosis) 
 Utilised thresholds were subject of regular 
legal proceedings 
 Hospitals that do not meet the MVSs 
are not allowed to conduct the 
particular surgery 
 In case of service provision, despite 
violations of MVSs, no reimbursement 
is provided for that particular surgery 
 Exemption clause: Hospitals can be 
exempt from the prohibition of 
providing services, when elective 
procedures cannot be provided from 




MVSs for 4 different sets  
of procedures and diagnosis 
set by CCO: 
 Lung cancer operations 
 Esophageal cancer surgery 
 Hepatic, and pancreatic, 
biliary tract surgery 
 Gynecologic oncology 
MVSs are based on: 
 Evidence based analysis 
 Existing recommendations from other 
jurisdictions 
 Expert opinion based on experience and 
consensus (main basis, because the quality 
of supporting evidence from the volume-
outcome literature is gauged to be modest) 
 CCO provides guidelines, reviewing data 
and indicators, organising community of 
practice events, education and potentially 
funding agreements with penalty for  
non-compliance 
 No legal regulation of MVSs provided by 
CCO (consequences not legally binding) 
 Reimbursement: Global budget plus 
additional payments for additional 
cases to reduce waiting times. CCO  
can withdraw some of the funding of 
additional cases, if not satisfied with 
the hospitals implementation of the 
organisational guidelines 


































Country Procedures Characteristics, Requirements and Evidence Organisational and legal framework Reimbursement and consequences 
Netherlands MVSs recommended  
by 2 expert societies for: 
 Cancer care for specific 
tumour types (SONCOS) 
 Oncological and 
gastrointestinal surgery, 
surgery of the lung, 
vascular surgery, 
traumasurgery, and 
pediatric surgery (NVvH) 
 Quality standards and MVSs are based on 
the consensus of all involved professional 
associations with an annual update based 
on suggestions by the associations 
(SONCOS) 
 Thresholds are based on expert opinion and 
evidence because there is no conclusive 
evidence for single thresholds. MVSs are 
annually updated (NVvH) 
 No explicit legal basis for the quality 
standards by SONCOS and NVvH 
 NVvH and SONCOS (yearly) publish 
reports on QS for MVSs 
 QS are highly respected and valued due  
to the commitment by the professional 
associations (SONCOS) 
 Once the standards (NVvH) are established 
they are enforced as field norms by the 
Dutch Healthcare Inspectorate, IGZ 
 Adherence to the QS of SONCOS are 
utilised for price negotiations between 
hospitals and the Dutch health care 
system. If targets are not met, then it 
is possible that this service is not 
reimbursed (SONCOS) 
 MVSs are also used for superintendece 
by the IGZ. E.g. medical errors due to 
lack of experience/non-compliance can 
lead to a prohibition of the respective 
surgery in the particular hospital 
Switzerland MVSs set for the following 
procedures: 
 Visceral surgery 
(esophageal, pancreatic, 
liver, deep rectal resection, 
and complex bariatric 
surgery) 
 Neurosurgery 
 Treatment of strokes 
 MVSs are assumed to be an internationally 
recognised quality criterion 
 Need for MVSs by referencing to 
international studies, e.g. MVS for 
visceral surgery and its re-evaluation 
(2016) based on scientific evidence 
 Since 2011, cantons are mandated by  
law to conceptualise a strategy on HSM 
including MVSs called inter-cantonal 
agreement on HSM 
 Allocation of services conducted by the 
scientific body of the IVHSM is dependent 
on MVSs by law of health insurances 
 Hospitals can apply for allocation of 
specific services and need to fulfil the 
requirements defined by the 
agreement on HSM (IVHSM) 
 To be eligible for allocation, the 
respective MVSs have to be met 
 Surgeries with MVSs that are not 
attained are not allocated to the 
respective hospital anymore 
CCO – Cancer Care Ontario, G-ZG – Gesundheits-Zielsteuerungsgesetz, HSM – Highly specialised medicine, IGZ – Inspectie voor de Gezondheidszorg (Dutch Healthcare Inspectorate),  
IQWiG – Institut für Qualität und Wirtschaftlichkeit im Gesundheitssystem (Institute for Quality and Efficiency in Health Care), IVHSM – Interkantonale Vereinbarung für HSM (Inter-cantonal 
Agreement on Highly specialised medicine), MVSs – Minimum Volume Standards, NVvH – Nederlandse Vereniging voor Heelkunde (Dutch Assoc. of Surgeons), ÖSG – Österreichischer Strukturplan 
Gesundheit (Austrian structural plan health), PRIKRAF – Privatkrankenanstaltenfinanzeriungsfonds (Private hospital financing fund), QS – Quality standards,  
SONCOS – Stichting Oncologische Samenwerking (Dutch foundation for oncologic cooperation) 
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5.4 Claimed benefits and consequences 
Based on the practice makes perfect hypothesis in the volume-outcome relation-
ship (VOR), MVSs find themselves being part of the debate on steady im-
provement of the health system and its provided services. They are expected 
to improve outcomes with regard to two aspects: 
 Quality aspects: (Clinical) Effectiveness and Clinical Safety 
 Economic aspects: Production Efficiency and Economies of Scale 
Whereas (clinical) effectiveness and safety is understood as outcome and qual-
ity of outcome, efficiency is conceived as an optimal input-output mix of re-
sources. Economies of scale suggests cost advantages in the scale of operation 
in the economic sense [105]. 
Against this background, MVSs in day surgery are not only associated with 
quality and safety, but additionally target economic aspects. Therefore, MVSs 
are especially attractive for health care planners as a policy tool (to counter-
act rising costs and ensure an efficient health care system) and for hospitals 
or care units (to benefit from increased profitability due to lower costs). 
 
5.4.1 Quality aspects 
In the context of quality development and evaluation in health care, MVSs 
can be embedded in the Donabedian model of quality in medical care [19, 
106]. The Donabedian model distinguishes between three dimensions of qual-
ity: structural, process, and outcome quality. Table 5-2 gives an overview and 
explanation of the three dimensions with examples in the day surgery setting 
[7, 107]. 
Table 5-2: Donabedian model of quality in medical care with regard to the day surgery setting 
Dimension Explanation Factors in the day surgery setting 
Structural Quality Structual quality includes human 
personnel, facilities and technical 
equipment, as well as organisational 
and other characteristics of the system 
that can be attributed to training and 
ability improvement 
Structural factors: 
 Surgery personnel: Level of training and 
skill set of surgeons and non-physician 
care team members ↔ Volume 
 Hospital/care unit: Management of the 
hospital or care unit ↔ Volume 
Process Quality Process Quality concerns the 
procedures that are perfomed for the 
patients. This comprises of clinical as 
well as non-clinical procedures such  
as admission process etc. 
Process factors (perioperative phase): 
 Pre-operative: Anaesthesia, diagnostic  
and screening procedures 
 Intra-operative: Surgery (techniques)  
and surgery related tasks 
 Post-operative: After-care 
Outcome Quality Quality of Outcome is WHAT is 
realised. This dimension comprises  
of improvement of health specific 
outcomes such as mortality or 
morbidity, but also achievements that 
are associated with PROMs or PREMs 
are included 
Outcomes: 
 Mortality, morbidity, Complications  
and AEs/SAEs 
 Readmission, rehospitalisation 
 PREMs/PROMs 
 etc. 
AEs – adverse Events, PREM – patient-reported experience measures, PROM – patient-reported outcome measures,  
SAEs – serious adverse events  
MM als Bestandteil  
in der Debatte über  









MM können in das 
Donabedian-Qualitäts-
modell für medizinische 
Versorgung eingebettet 
werden 
Description of minimum volume standards and current use 
LBI-HTA | 2019 47 
 
MVSs are expected to target the structural quality. Via this dimension, MVSs 
are seen as an intermediate step to increase quality of outcome and serve as a 
tool to preserve a certain quality level [18]. It is expected that implementation 
of MVSs improves the level of training and the abilities of the surgical person-
nel as well as the management abilities of care units. In the end, only quali-
fied and experienced surgeons, surgical teams, or care units perform particu-
lar surgeries that are affected by MVSs. Better outcomes compared to situa-
tions without MVSs regulations are expected to emerge [7]. 
Minimum volume requirements that are located in the structural quality di-
mension should not be considered as the only exclusive factor enhancing qual-
ity. A prerequisite to make inferences about overall quality is to understand 
the interrelation of these three dimensions. It is not recommended to neglect 
the other two dimensions, otherwise a successful pathway in day surgery can-
not be realised. Patient-related factors and process related factors such as over-
all preoperative preparation, anaesthetic management, postoperative recovery 
and discharge, or follow-up are also relevant for successful and high-quality 
day surgeries [19, 20]. 
 
5.4.2 Economic aspects 
In a system with scarce resources, such as the health care system, it is always 
crucial to consider costs, outcomes, and their distribution. This holds espe-
cially true when from the theoretical standpoint, the quality of care and health 
expenditures could be related with each other [108-110]. 
In theory, MVSs are expected to increase production efficiency and reduce 
costs in addition to the expected cost-reducing day surgery setting. Two ef-
fects appear relevant for the health care sector that can be attributed to the 
cost-effective nature of MVSs (Table 5-3). On the one hand, production effi-
ciency is induced by a learning effect that could lead to improved outcomes. 
It is expected that high-volume surgeons or hospitals meeting the efficient 
MVSs threshold are superior to low-volume providers in quality and efficien-
cy aspects because the former are more likely to choose an appropriate treat-
ment. On the other hand, costs are reduced on account of economic theory in 
the form of economies of scale. Both effects are assumed to reduce the long-
run costs. 




Facilities, technical equipment, and personnel are utilised in a productivity-efficient 
way (on the production possibility frontier). E.g. with increasing volume, surgeons 
are expected to become better and care units improve their organisational abilities 
resulting in lower resources and costs used in the long run. 
Economies of Scale Economies of scale are present if with increasing prodcution, average costs are 
decreasing. With increasing surgery volume, care units experience a decrease in 
fixed costs to a certain point and thereby lower their average cost per patient [111]. 
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The evidence that production becomes more efficient with more experience in 
monetary terms has been mainly shown in industrial production [6, 8]. While 
the focus in industrial production is on accumulated experience in form of 
accumulated volume, accumulated experience over many years is disputable 
as a single explanatory factor for medical services. It is rather the mainte-
nance of ability or routine combined with experience accumulation over life-
time and the training period of a young surgeon that are deemed relevant [8, 
9]. These issues are mostly addressed by health economic literature [9, 105]. 
According to empirical findings and the mentioned theoretical considerations, 
production efficiency and economies of scale appear relevant for the health 
care sector (Table 5-3). The cost-effective nature of increased surgeon volume 
was empirically tested in some studies for a set of procedures such as thyroid-
ectomy, adrenal surgery, total ankle arthroplasty, and many other interven-
tions in the inpatient setting [112-116]. For the day surgery setting, further 
surgery specific economic evaluations are necessary for a more concrete assess-
ment of the economic dimension of an increased surgeon volume and MVSs. 
It is essential to verify the range of output over which costs are expected to 
fall, and the scale at which costs may start to increase again because of dise-
conomies of scale. 
Overall, using resources in a production efficient way at the hospital level 
does not necessarily guarantee efficiency on an aggregated (health care sys-
tem) level because negative external effects such as inequity of access are not 
taken into account. 
MVSs are also associated with concentration of surgical procedures and the 
formation of excellence centres, where only qualified and experienced sur-
geons and surgical teams perform surgeries. This concentration process of ser-
vices due to implemented MVSs has been empirically described by a study 
for complex procedures in the German inpatient setting [117]. Another as-
sumption is that centralisation with formation of excellence centres leads to 
quality improvement and efficiency gains by reducing unit costs for hospi-
tals by economies of scale (Table 5-3) and releasing resources that can be 
used in other service areas [7, 9]. An international study verified this pre-
sumption for highly specialised procedures by critically assessing concentra-
tion policies [118]. To what extent this centralisation process applies for the 
day surgery setting is not clear. 
 
5.4.3 Quality of access and further consequences 
of minimum volume standards 
However, on a social welfare level, the effect of centralisation of surgical ser-
vices induced by MVSs can only be beneficial and sustainable if patient out-
comes of the whole population certainly improve with increasing hospital vol-
ume. One critical argument is that centralisation caused by minimum quan-
tities leads to a deterioration of quality of supply and health service coverage. 
It could increase inequities in access to quality care in form of increased trav-
eling distance to the next hospital or ambulatory care unit. This seems espe-
cially crucial for vulnerable groups such as people with socio-economic dis-
advantages or elderly people that experience a limited accessibility to health 
care not only with regard to proximity. Furthermore, centralisation could af-
fect patients’ autonomous choices, as they will have little or no choice between 
different health care institutions. 
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Another point is that a centralisation due to MVSs may endanger the coordi-
nation and continuity of care, as well-established local networks between the 
various medical service providers lose their importance and competition be-
tween health care providers decreases. Residency and education capacities 
are affected by centralisation that have to be taken into account in health 
planning. Exemption rules from MVSs are of utter importance, e.g. in case 
of long periods of illness of the respective surgeon or for regions with a seri-
ous shortfall. 
Apart from that, a related counterargument against MVSs is that surgeons or 
hospitals focus only on complying with the minimum requirements in the 
course of their quality management and neglect other structural- or process 
related measures of quality improvement such as adhering to procedure guide-
lines [7]. An oversaturation effect when relying on pure volume as a quality 
measure is also possible, especially, when no optimal minimum volume thresh-
old is utilised. Outcomes can deteriorate when a surgeon conducts too many 
surgeries, because she or he is inattentive. 
The important question of unnecessary health care in the form of overtreat-
ment or over-utilisation and its underlying determinants is scarcely addressed 
by the studies testing the practice makes perfect hypothesis. It is feared that 
costly controls of appropriate indications will become necessary, as minimum 
quantities could lead hospitals or surgeons making more generous indication 
decisions if they are closely just below the minimum quantity. This argument 
is important to consider in the context of low-risk procedures and demands a 
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6 Organisational aspects and 
policy implications in the Austrian context 
6.1 Implementation requirements 
In general, the dynamic nature of the health system makes it imperative to 
consider also organisational implications and consequences when developing 
and implementing criteria for quality assurance and quality standards. The 
IAAS and the BADS suggest that audit and subsequent action is elementary 
for the successful practice of ambulatory and day surgery [87, 119]. Both as-
sociations propose that surgical programmes should be steadily monitored to 
guarantee high quality services. Before monitoring and benchmarking can be 
operationalised, the respective quality standard under consideration and cor-
responding outcome measures are imperative to ensure a safe, effective, and 
efficient setting in day surgery. To achieve this, establishing key principles 
that reinforce the implementation of quality standards is key [35, 36]. 
In Austria, due to the fragmented health care system with different legal re-
sponsibilities, considering organisational implications and consequences re-
lated to MVSs in day surgery appear to be particularly essential. According to 
the federal contract on Target-Based Governance (Vertrag zur Zielsteuerung-
Gesundheit auf Bundesebene – B-ZV) according to article 15a of the federal 
constitutional law and the federal law on quality of health services (Art. 15a 
B-VG über die Organisation und Finanzierung des Gesundheitswesen, B-VG 
Zielsteuerung-Gesundheit and Gesundheitsqualitätsgesetz – GQG), agreed 
by the federal government, the Main Association of Austrian Social Security 
Institutions (Hauptverband der österreichischen Sozialversicherungsträger, 
HVB) [49, 50, 120], all contract parties committed themselves that assurance 
and further development of the quality of care have top priority and are car-
ried out nationwide, across federal states, sectors and occupations. This also 
relates to a comprehensive, comparable, and standardised quality measure-
ment in the intramural (inpatient and ambulatory care in the hospital) and 
extramural (ambulatory care in the outpatient setting including contracted 
private practice) setting and the specification of optimal quality standards.  
Internationally, there are established programs for the provision of quality 
standards such as programs provided by Health Quality Ontario (HQO) and 
the National Institute for Health and Care Excellence (NICE) [36, 37]. Such 
process guides not only make standards available to all relevant stakeholders 
and the public, but also provide indicators to measure quality. In Austria, 
the Austrian Public Health Institute (Gesundheit Österreich GmbH – GÖG 
GmbH) on behalf of the Austrian Ministry for Labour, Social Affairs, Health, 
and Consumer Protection (BMASGK) recently published an updated version 
of their methodological handbook for establishing quality standards (Metho-
de zur Erstellung von Qualitätsstandards) based on the mentioned process 
guides from NICE and HQO [38]. The handbook proposes a three-step pro-












Implikationen und  
Konsequenzen von  




NICE und HQO stellen 




Minimum volume standards for quality assurance in day surgery 
52 LBI-HTA | 2019 
Table 6-1: Three-step procedure for developing quality standards in Austria 
Phase Explanation 
Determination of the core 
elements of the standards 
“In the first preparation phase, a brief overview of the initial situation 
including potential fields of action is to be drawn up, on the basis of which the 
constituent advisory board defines the core elements of the quality standard.” 
Creation of the  
quality standard 
“The second phase comprises the creation of the quality standard itself. It must 
be structured uniformly; the respective recommendation chapters are structured 
according to a defined scheme. After researching evidence of potentially 
effective measures to improve the quality of care in the respective field of action, 
the recommendations are formulated and justified. With regard to measurability 
and verifiability, quality indicators for the individual recommendations should 
be proposed (if possible). The advisory board comments on the draft quality 
standard, followed by quality assurance through at least two external expert 
reviews and public consultation. Afterwards, the authors finalise the quality 
standard with the involvement of the advisory board.” 
Political and 
organisational 
implementation of  
a quality standard 
“The third phase, the political and organisational implementation of a  
quality standard, cannot be described in the methods manual, as concrete 
implementation steps generally take place at country level taking into account 
regional conditions and requirements. In order to disseminate the contents of 
the quality standard, however, its broad publication should be ensured. The 
validity of a quality standard is usually set at five years. In good time before  
its expiry, it should be evaluated and checked for updating requirements.” 
 
A legitimised quality standard that should be legally binding is more likely 
to be accepted and complied with by the affected entities. It further promotes 
enforcement of possible deviations if a scientifically correct and uniform meth-
od for implementation is ensured. As defined in the third step of the quality 
standard development process in Table 6-1, the political and organisational 
implementation of a quality standard cannot be described in a method hand-
book, as concrete implementation steps generally take place at the national 
level in order to take into account regional differences and requirements [38]. 
However, after completion of the quality standard, some downstream proces-
ses such as monitoring still need to be considered. 
 
 
6.2 Use and Maintenance (Monitoring) 
Questions related to the external validity, monitoring and the associated (re-
gulatory) framework of MVSs in the day surgery context remain mostly un-
answered in the literature investigating the VOR [10, 13]. Generally, wheth-
er administrative MVSs in day surgery are useful, is not only highly depend-
ent on scientific evidence, but also on the ability to integrate them into exist-
ing monitoring frameworks to identify possible consequences. Consequences 
may include possible gaps in comprehensive care, change in waiting times, 
supply bottlenecks, shifting of patient flows, or excessive burdens in hospitals 
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In the quality standard context, monitoring can be understood as maintain-
ing periodic surveillance of performance in a systematic manner on various 
levels. Self-evaluation is indeed important for quality assurance. Additional 
(external) monitoring by non-departmental public bodies or third party bod-
ies on national, regional, or sectoral level can support quality assurance by re-
ducing possible biases due to self-evaluation [121]. With regard to the health 
system, monitoring can be conducted on a micro-level, e.g. surgeon or hospi-
tal unit monitoring or on a macro-level, i.e. national or international monitor-
ing [119]. 
In Austria, the B-ZV stipulates an Austria-wide monitoring of the defined 
goals differentiated by sectors and regions, to be carried out at federal level 
and further developed in terms of content [50, 51, 120]. The respective moni-
toring based on administrative data (Routinedaten) is carried out by the Aus-
trian Public Health Institute including dissemination of a status report to 
pursue the objective of transparently presenting the realisation and progress 
of the objectives [122]. It constitutes an integral part of the reform process 
and represents the degree to which the objectives have been achieved at fed-
eral and state level. 
Strategic objective 1 in the federal B-ZV “aims to ensure needs-based supply 
structures by strengthening outpatient and ambulatory care while relieving the bur-
den on acute inpatient care and optimising the use of resources”. In addition, as 
part of operational objective 8, “Ensuring the quality of results in the entire out-
patient area”, the concept for measuring quality and measurement parame-
ters in the outpatient and ambulatory area is to be further developed. Hence, 
the operational strategic objective 1, operational objective 8 and the lack of a 
comprehensive quality measurement system including monitoring of the am-
bulatory sector opens space for the debate on MVSs and the respective moni-
toring responsibilities in Austria in the future [123, 124]. 
A comprehensive and uniform monitoring system, not only specifically for im-
plemented administrative MVSs, is imperative because of two reasons. First 
the contract parties committed themselves to quality in the health care sys-
tem, and second a comprehensive, comparable and standardised quality mea-
surement including monitoring in the inpatient (intramural) and outpatient 
(extramuraler/niedergelassener Bereich) area represents an essential basis for 
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7 Regulation for day surgery in Germany 
(Ambulantes Operieren) 
7.1 Legal framework 
7.1.1 Nationwide contracts and agreements 
In Germany, by now a wide range of surgical procedures can be performed on 
an ambulatory basis by (contracted) doctors in private practise (niedergelas-
sener Bereich). These include arthroscopies, cataract operations, biopsies, and 
more. In addition, in accordance with § 115 b para. 1 SGB V, the statutory 
health insurance (gesetzliche Krankenversicherung – GKV), the German Hos-
pital Federation (Deutsche Krankenhausgesellschaft – DKG) and the Nation-
al Association of Statutory Health Insurance Physicians (Kassenärztliche Bun-
desvereinigung – KBV) have agreed by contract to strengthen ambulatory 
surgery and substitute surgical procedures in the inpatient setting, which is 
in effect since 01.06.2012 with an editorial update in 2014. 
The contract for ambulatory surgery (so-called AOP contract) is intended to 
create a uniform framework for the performance of ambulatory surgeries and 
inpatient substituting procedures and to support the cooperation between con-
tracted private practice (niedergelassener Bereich) and the hospital sector. Its 
aim is to ensure patient-friendly and economic care on the basis of § 39 SGB V 
in order to avoid unnecessary inpatient hospital treatment and to improve co-
operation between private practice and the hospital sector, including the joint 
use of surgical capacities in the hospital. 
Supplementary to the AOP contract, they agreed on an associated uniform 
remuneration for hospitals and KBV-contracted physicians. The remunera-
tion system of the federal association of statutory health insurance physici-
ans (Einheitlicher Bewertungsmaßstab – EBM) regulates medical and ambu-
latory services to be provided at the expense of the statutory health insurance 
fund. Legal basis is § 87 paragraph 1 of the social security statute book V 
(SGB V) prepared by the evaluation committee consisting of the federal asso-
ciation of statutory health insurance physicians (Kassenärztliche Bundesverei-
nigung – KBV) and the German association of the statutory health insurance 
fund (GKV). Ambulatory surgery is administered in Chapter 31 of the EBM. 
All relevant surgeries for ambulatory surgery are listed in a catalogue – called 
AOP catalogue – which has been compiled by the KBV, the GKV and DKG 
in the course of establishing the AOP contract. Hospitals are obliged to re-
port ambulatory services to their regional association of the statutory health 
insurance funds (Landesverband der Krankenkassen) and the associations of 
the substitute funds (Ersatzkassen), the regional association of social health 
insurance physicians (Kassenärztliche Vereinigung – KV), and the admission 
committee (Zulassungsausschuss) in accordance with § 1 of the AOP contract. 
KBV-accredited physicians require approval from their respective regional 
KV to be eligible for ambulatory surgery. 
For some surgeries such as colonoscopy, invasive cardiology, arthroscopy, 
cataract surgery, photodynamic therapy (PDT), and phototherapeutic kerat-
ectomy (PTK) an additional approval must be obtained by the KV – in addi-
tion to the general approval to operate on an ambulatory basis. 
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The AOP contract specifies that minimum requirements according to the 
professional qualification have to be fulfilled for a successful approval of the 
specific surgery in the ambulatory setting (Facharztstandard/Fachliche Be-
fähigung). Furthermore, the contract stipulates that frequency requirements 
(Frequenzregelung) to maintain the approval to conduct ambulatory surgery 
have to be fulfilled.  
The AOP contract according to § 115b para. 1 SGB V states the following 
with regard to professional qualifications and frequency regulations [12]: 
“Medical services in accordance with § 115b SGB V are provided in accordance 
with the respective professional standard valid at the time of treatment. [...]” 
and 
“[...] Guidelines and resolutions of the Joint Federal Committee pursuant to 
§ 92 Paragraph 1 Sentence 2 No. 13 SGB V and pursuant to § 137 Paragraph 
1 Sentence 1 SGB V shall be taken into account. This concerns in particular 
the execution of hygiene controls, the adherence to the further structure quality 
as well as the adherence to frequency regulations. Frequency regulations are to 
be fulfilled physician-related [...]”5 
According to the KBV, in order to try to operationalise the definition of a fre-
quency, the limits often cannot be clearly defined according to the rules of 
evidence-based medicine, but are consensus-based values [125]. 
As part of the contract, the three parties (GKV, KBV and DKG) have laid 
down special quality measures in the corresponding agreement on “quality as-
surance measures according to § 135 para. 2 SGB V for ambulatory surgery" 
(quality assurance agreement for ambulatory surgery). All service providers 
including the KV are obliged to ensure and further develop the quality of their 
services and to adopt the specified structural quality requirements. In addi-
tion, a joint declaration of the contract partners also ensures that the struc-
tural quality requirements apply to ambulatory surgeries performed in the 
inpatient sector [126, 127]. 
The surgery specific minimum volume requirements to conduct the specific 
surgery (professional standard) and the frequency requirements to continue 
the specific surgery are specified in corresponding quality agreements in ad-
dition to the general agreement on “quality assurance measures according to 
§ 135 para. 2 SGB V for ambulatory surgery”. Table 7-1 in section 7.3 shows 
the day and ambulatory surgeries for which specific minimum frequencies are 
defined. 
The frequency regulation is similar to the minimum volumes for the inpa-
tient sector according to § 136b Abs. 1 Satz 1 Nr. 2 SGB V that determine the 
amount of the respective annual minimum quantity per physician and/or hos-
pital location for selected plannable inpatient services for which the quality 
of the treatment outcome depends on the quantity of services provided. 
 
 
                                                             
5 Authors translation 
AOP-Vertrag spezifiziert 
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7.1.2 Regional level:  
Structural contracts/Special Care 
As mentioned before, some surgeries need additional approval by the region-
al KV and can also be part of so-called structural contracts. These regional 
contracts are intended to broaden the scope for health insurance funds and 
the 17 KVs to design their own policies and remove bureaucratic obstacles of 
selective contracts. This includes differentiated fee systems, but also addi-
tional minimum volume requirements can be part of these contracts. 
The agreement of structural contracts in accordance with § 73a SGB V was 
possible until July 2015. With the SHI Health Care Strengthening Act (GKV-
Versorgungsstärkungsgesetz), this type of contract was replaced by “special 
care” in accordance with § 140a SGB V (§ 140a SGB V Besondere Versor-
gung). Structural contracts already contracted continued to apply. In practice, 
the structural contracts mainly concern practice networks or ambulatory sur-
gery including minimum volume and frequency requirements [128]. 
 
 
7.2 Monitoring and Reporting 
The KVs are obliged by law to promote quality in the ambulatory setting of 
KV-accredited physicians according to § 135b para. 1 SGB V. One aspect of 
this task is the audit of minimum volumes and the frequency regulation. The 
regional KVs regularly check whether physicians meet the minimum number 
of examinations and treatments prescribed. Once the required number of cas-
es has been reached, the audit is completed. If the minimum quantities are 
not provided within the specified period, the billing authorisation is revoked 
and the doctor may no longer provide the examination at the expense of the 
statutory health insurance [125]. 
Furthermore, the documentation and publication of the objectives and re-
sults by the KVs are further aspects in the course of promoting quality in the 
ambulatory setting. The presentation of the quality of ambulatory care is con-
ducted in the course of an annual quality report by the KV and KBV. The 
data basis consists of a systematic evaluation of the electronic documenta-
tion provided by the KV-accredited physicians in the course of their docu-
mentation obligation, random individual case examinations and, in rare cas-
es, medical practice inspections. 
The annual reports contain detailed information on the type, scope, and re-
sults of the quality promotion measures undertaken on about 50 topics of am-
bulatory care at federal and KV level. The reporting is largely performed on 
an aggregated level [125]. Data reporting at the institution level is not intend-
ed in the KBV quality reports. Part of the published report are number of 
approved physicians to ambulatory surgery, number of approved ambulatory 
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7.3 Frequency regulation for specific 
surgeries 
Table 7-1 gives an overview of the specific procedures that are affected by a 
volume regulation framework in the German context. The table provides in-
formation on nationwide frequency requirements (seven interventions) and 
minimum requirements set by the regional KVs in structural contracts on 
the following aspects: 
 Procedure(s), 
 Minimum volume requirements to be approved for conducting  
the surgery in the ambulatory setting (professional standard), 
 Frequency requirements to maintain the professional qualification 
defined in the respective quality assurance agreement or regional 
structural contract for the specific surgery, 
 Consequences of non-compliance with frequency requirements,  
and 




































Table 7-1: Minimum volume and frequency requirements for ambulatory surgery (Ambulantes Operieren) in Germany 
Procedure (1.) Minimum volume and (2.) frequency requirements 
(3.) Consequences of Non-Compliance with frequency requirements 
and (4.) Restoring of allowance 
Nationwide frequency requirements/regulation in the AOP contract according to § 115b paragraph 1 SGB V 
Arthroscopy [129] (1.) If facultative further education/training in “special orthopaedic 
surgery” in the field of orthopaedics was not completed, the surgeon 
has to certify 180 independently conducted arthroscopic surgeries 




Diabetic foot treatment7 
(ablation of extended 
necroses) [130] 
(1.) NA 
(2.) Treatment of at least 100 patients with diabetes mellitus per 
quarter on average over the last 4 quarters prior to treatment 
application. 




(1.) Independent performance of at least 200 total colonoscopies/ 
50 polypectomies under guidance of an authorised physician within 
a period of 24 months. 
(2.) Independent performance of at least 200 total colonoscopies/ 
10 polypectomies without deficiencies in accordance with the quality 
assurance agreement colonscopy within a period of 12 months. 
(3.) The KV shall determine whether the required evidence has been 
provided. If no evidence has been provided, the KV shall immediately 
inform the physician thereof. 
If the inspection reveals deficiencies according to the quality 
agreement colonscopy or if less than 200 total colonoscopies/ 
50 polypectomies have been carried out, the authorisation shall  
be withdrawn. 
(4.) Approval shall be restored upon application if the physician can 
prove that she/he has performed at least 50 total colonoscopies, 
including the required polypectomies, under the supervision of an 
authorised physician, within six consecutive months of revocation of 
approval. In this case, the other licensing requirements according to 
the general approval to conduct ambulatory surgery do not have to 
be proven again. 
Colposcopy8 (comes into 
force in 2020) [132] 
(1.) - (3.) If the evidence cannot be provided again after further 12 months, 
the authorisation to perform and bill for this service shall be revoked. 
                                                             
6 30 of the 180 surgeries need to be special arthroscopic surgeries such as surgeries with meniscus, plica, Hoffa’s fat pad resection and/or removal of corpora liberia,  
cartilage smoothing, microfracture surgery, patella shaving, lateral release and/or removal of meniscus ganglion, synovectomy, curettage, fixation of a detached cartilage  
fragment etc. For a full list see the respective quality assurance agreement for arthroscopic services [83]. 
7 According to the German diabetes society, inpatient admission is only indicated for severe (or moderate) infections. 
8 If medically indicated, colposcopically controlled biopsies from the most severe lesions (transformation zone type 1 and type 2) and an endocervical curettage  
































Procedure (1.) Minimum volume and (2.) frequency requirements 
(3.) Consequences of Non-Compliance with frequency requirements 
and (4.) Restoring of allowance 
Colposcopy8 (comes into 
force in 2020) [132] 
(Fortsetzung) 
(2.) Annual provision of evidence of at least 100 clarification 
colposcopies with abnormal findings of portio, vagina and vulva and 
at least 30 histologically confirmed cases of intraepithelial neoplasia 
or invasive carcinomas in the last 12 months. Annual proof of regular 
participation (at least 2 times per half-year) in interdisciplinary case 
conferences (e.g. tumour conferences). Personal attendance or in 





(1.) Independet implementation of 100 intraocular interventions 
(without laser therapy) 






(1.) Independent diagnosis and documentation of at least 500 
diagnostic vascular imaging or therapeutic interventions, of which 
at least 250 are catheter-assisted under guidance within the last 5 
years prior to the application for approval. The catheter-assisted 
therapeutic interventions must include at least 100 vasodilative and 
at least 25 vascular-obliterated interventions. 
(2.) Independent indication, diagnosis and documentation of 100 
diagnostic vascular imaging or therapeutic interventions, of which 
at least 50 are therapeutic interventions, if necessary including 
aftercare, within a period of 12 months. 
(3.) KV determines whether the required evidence has been provided.  
If no evidence has been provided, the KV shall immediately inform the 
physician thereof. If the evidence cannot be provided again after a period 
of 12 months following the first period, the authorisation is revoked. 
(4.) Permission to perform diagnostic catheter angiographies and 
therapeutic interventions is granted again upon application if the 
physician can prove that she/he has performed at least 50 diagnostic 
catheter angiographies or catheter-assisted therapeutic 
interventions, of which at least 25 therapeutic interventions, under 
the supervision of an authorised physician, are done within six 
consecutive months of the revocation of permission. In this case, the 
other licensing requirements do not have to be proven again. 
Vacuum biopsy of the 
breast [135] 
(1.) Independent indication and implementation of 25 punch biopsies 
under ultrasound control and 25 vacuum biopsies under guidance 
within the last 2 years before application 
(2.) Independent performance of at least 25 vacuum biopsies within 
a period of 12 months. 
(3.) The KV determines whether the required evidence has been 
provided. If the evidence has not been provided, the KV shall inform 
the physician immediately. 
(4.) If the proof cannot be provided again after the expiry of the 
initial period of 12 months, the authorisation shall be revoked. 
The authorisation is restored on application if the doctor can prove 
that she/he has carried out at least 25 vacuum biopsies under the 
supervision of an authorised doctor within 6 months of revocation 
of the authorisation. In this case, the other licensing requirements 
need not be proven again. 
                                                             































Procedure (1.) Minimum volume and (2.) frequency requirements 
(3.) Consequences of Non-Compliance with frequency requirements 
and (4.) Restoring of allowance 
Structural contracts of the respective KV/regulation in the quality assurance agreements according to § 140a SGB V. 
Cataract surgery 
KV Bayern [136] 
(1.) At least 400 cataract surgeries independently performed until 
the date of submission of the declaration of approval (surgeries 
conducted in the inpatient setting can be credited). 
(2.) At least 50 ambulatory cataract surgeries must be performed  
per quarter on an annual average. 
(3.) Withdrawal of the right to participate 
(4.) Entitled to participate again at the earliest after two full quarters. 
This requires a renewed submission of a declaration of participation 
by the physician as well as a renewed granting of the participation 
permit after examination of the general requirements. 
Cataract Surgery 
KV Sachsen-Anhalt [137] 
(1.) NA or rather SHI-accredited ophthalmologist 
(2.) At least 200 cataract surgeries per year 
(3.) Participation is terminated, if the requirements and contractual 
arrangements laid down are no longer met or complied with. 
(4.) NA 
Cataract Surgery 
KV Nordrhein [138] 
(1.) At least 100 cataract surgeries independently performed  
in the last 4 quarters 
(2.) A minimum of 100 cataract operations per year 
(3.) In the following year the doctors will be excluded from 
participation in the following quarter on by notification. 
(4.) NA 
Retinal and vitreous 
surgery (vitreoretinal 
surgery) 
KV Nordrhein [139] 
(1.) In total, the following operations must have been carried out in 
the last 10 years: 50 independently conducted denting operations in 
retinal detachments as (not in the context of other procedures such 
as pars plana vitrectomies), 300 pars plana vitrectomies (PPV), of 
which at least 80 pars plana vitrectomies in diabetic retinopathy,  
70 pars plana vitrectomies in rhegmatogenic retinal detachment or 
proliferative vitreoretinopathy, 70 pars plana vitrectomies in macular 
diseases, 5 pars plana vitrectomies in trauma (p.rimary care and/or 
vitreoreticomplications after trauma) 
Proof of evidence of at least 150 further specified retinal/vitreous 
surgeries in the last 8 quarters prior to application for participation 
in the contract. (includes all denting operations and pars plana 
vitrectomies with or without retinal/vitreous surgery or without 
supplementary procedures on the posterior segment of the eye, but 
not only intravitreal drug injections). 
(2.) NA 
(3.) Participation in the contract ends as soon as the participating 
ophthalmic surgeon does not or no longer completely fulfil the 
conditions for participation and in the event of breach of contractual 
or professional obligations. 
(4.) NA 
The KV Nordrhein agreed on a contract to promote ambulatory surgery and inpatient subsituting services. The contract includes minimum frequencies for 4 specialities 
(surgery/orthopaedics, otorhinolaryngology, gynaecology, urology). Whether these frequencies serve for quality assurance cannot be inferred on the basis of the available 
documents [140]. 
KV – Kassenärztliche Vereinigung (regional Association of Social Health Insurance Physicians), NA – not available, “-“ indicates that this point is not relevant for the specific intervention,  
because consequences and re-storing allowance are dependent on existing frequency requirements and not minimum volume requirements (professional standard) 
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8 Clinical effectiveness of minimal volumes 
8.1 Outcomes 
Provided that seven different indications are analysed in the scope of this as-
sessment, an extended list of efficacy outcomes is considered crucial to derive 
a recommendation: 
 Survival rate 
 Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) score 
 Revision surgery 
 Hospital visit within 30 days 
 Non-routine disposition of patients at discharge 
 Length of stay (LOS) 
Further outcomes included in the assessment were: 
 Re-admission including admission for 23 hrs observation  
and full admission (obs. longer than 24 hrs) 
 (Risk-adjusted) Incidence of postcataract surgery endophthalmitis 
 Reduction in pain score units on visual analogue scale (VAS) 
 Mean operating time 
For the intervention of thyroidectomy (outpatient thyroid surgery), discharge 
on the day of surgery, admission for 23 hrs observation and full admission 
(longer than 23 hrs) were measured and assessed in relation to surgeon volume. 
For the intervention of cataract surgery (general), (risk-adjusted) incidence 
of post-cataract surgery endophthalmitis was assessed in relation to annual 
surgeon volume. Reporting of endophthalmitis was done with respect to total 
endophthalmitis (TE) cases, overall endophthalmitis rate per 1,000 surgeries 
(ERpT), relative risk of endophtalmitis (RR), and risk-adjsuted relative risk 
of endopthalmitis (RARR). The risk-adjustment was applied with regard to 
age, gender, ethnicity, year, ambulatory surgery centre, and surgeon experi-
ence in years. Also, the outcome of risk of revision surgery was determined 
in relation to surgeon volume. Revision surgery included placing of a poste-
rior chamber or sulcus intraocular cataract lenses (IOL) and placement of an-
terior chamber IOLs. 
For the intervention of hip arthroscopy, survival rates at two, five, and ten 
years were measured and assessed in relation to surgeon volume. Also, the 
outcome of risk of reoperation was measured in relation to surgeon volume. 
Reoperation included revision scope, resurfacing, or total hip arthroplasty. 
For the intervention of open carpal tunnel release, BCTQ score was meas-
ured at six weeks, three months, and six months postoperatively. It was as-
sessed in relation to surgeon volume. Two domains of BCTQ were assessed in 
particular: the Symptom Severity Scale (11 items) and the Functional Status 
Scale (8 items). Each item consists of five response categories ranging from 
one to five, where higher score represents worse symptoms/lower level of func-
tion. Responses to items were averaged to create an overall score for each do-
main. Also, the secondary outcome of reduction in pain score units on VAS 
was assessed in relation to surgeon volume. The scale ranged from 0 to 100 
and was measured six weeks, three months, and six months postoperatively. 
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For the intervention of rotator cuff repair, the outcome of non-routine dis-
position of patients at discharge was assessed in relation to surgeon as well 
as hospital volume. Non-routine disposition includes transfer to another hos-
pital, skilled nursing facility, intermediate care facility, or home health care 
(health care provided at home by licensed health professionals). Routine dis-
position reflected patients who were discharged home. Also, the outcome of 
length of hospital stay (LOS) was assessed with respect to surgeon and hos-
pital volume. LOS was divided into two categories: less than 1 day and great-
er than or equal to 1 day – that was termed extended length of stay. The out-
come of mean operating time was assessed as well in relation to hospital and 
surgeon volume. Operating room time was calculated in minutes for every 
procedure and defined as the total time spent in the operating room exclusive 
of preoperative and postoperative time. 
For the interventions of anterior cruciate ligament reconstruction and menis-
cectomy, the outcomes of non-routine disposition of patients at discharge and 
LOS (described above) were used. Also, the outcome of inpatient hospital ad-
missions or emergency department visits within 30 days of ACL surgery was 
assessed in relation to hospital volume.  
 
 
8.2 Included studies 
For the assessment of clinical effectiveness, eight studies met the inclusion 
criteria. One of the studies had a control group [21], however, none of the 
studies was done prospectively – all the studies were retrospective. Two stud-
ies were found on the intervention of ACL reconstruction [23, 26], two on 
cataract surgery [22, 24], and one for each of the following interventions: me-
niscectomy, thyroidectomy, primary hip arthroscopy, open carpal tunnel re-
lease, and rotator cuff repair [21, 25, 27, 28]. 
 
Study characteristics 
While two studies were single centre analyses [21, 22], the remaining six stud-
ies were analyses of health care databases [23-28]. Seven studies were con-
ducted in the US [21-26, 28] and the eighth study was conducted in the Neth-
erlands [27]. Information about study sponsors was not disclosed in five stud-
ies [21-23, 25, 26], two studies were funded by the NIH/NIAMS [27, 28], and 
one study was funded by the NEI [24]. Two studies did not report on conflict 
of interests (COI) [25, 26], four studies reported that none of the authors had 
COI [22-24, 27], and two studies reported COI of one of their authors [21, 
28]. The dates of data collection in all the studies was between 1997 and 2015. 
All the studies gathered data on the outpatient setting and while four studies 
analysed the VOR from the perspective of surgeons [22, 24, 27, 28], one ana-
lysed it from the hospital perspective [23], and three from the perspectives 
of both surgeons as well as hospitals [21, 25, 26]. Follow-up time was not re-
ported in five studies [21, 22, 24-26], it was ten years in [28], six months in 
[27], and 30 days in [23]. 
 
OP der RM:  
nicht-routinemäßige 








Disposition bei der  
Entlassung und 
stationäre Aufnahme 
8 Studien erfüllten die 
Einschlusskriterien, 
keine Studie wurde 
prospektiv durchgeführt 
2 Single-Center-Studien 
und 6 Analysen  
anhand von Daten aus 
Gesundheitsdatenbanken 
 
7 Studien aus den USA 
und 1 aus den 
Niederlanden 
4 Studien nahmen eine 
ChirurgInnensicht,  
1 Studie eine 
Krankenhaussicht und  
3 Studien eine 
kombinierte Sicht ein 
Clinical effectiveness of minimal volumes 
LBI-HTA | 2019 65 
Patient characteristics 
The analysis of primary hip arthroscopy included 7,836 patients and 8,267 
procedures that were performed by 295 surgeons in 137 centres [28]. The 
analysis of carpal tunnel release included 1,345 patients/procedures (712 pa-
tients not followed-up) performed by 17 surgeons in 11 centres [27]. The anal-
ysis of rotator cuff repair included 9,973 patients (961 not followed-up) [25], 
ACL reconstruction included 45,262 patients (14,050 not followed-up) [23, 26], 
and the analysis of meniscectomy included 123,012 patients (72,585 not fol-
lowed-up) [26]. The number of procedures, surgeons, or surgical centres was 
not reported in the three studies above. For the single centre analysis of thy-
roidectomy, 109 outpatient and 51 inpatient patients were included with 35 
and 26 procedures respectively [21]. For the analysis of cataract surgery, 
2,289,307 patients were included (200,520 not followed-up) with 3,280,966 pro-
cedures conducted by 22,877 surgeons in an unclear number of centres (ex-
cept for four surgeons that were part of a single centre analysis [22]). Because 
of the retrospective nature of the studies, loss to follow-up was not reported. 
Surgeon as well as hospital volume was categorised into low, medium, and 
high (very high in one study [28]) and the thresholds differed with interven-
tions. The low volume threshold ranged from six to 411 interventions, while 
the high (or very high) threshold ranged from 30 to 1,336 interventions per 
year. Inclusion and exclusion criteria were heterogeneous as they varied with 
interventions. Co-interventions were reported in four studies [21, 23, 25, 27] 
and the mean age ranged from 29,4 to 73 years.  
Study characteristics and results of included studies are displayed in Table 
13-1 and Table 13-2 and in the evidence profile in Table 13-3. 
 
 
8.3 Quality of evidence 
on clinical effectiveness and safety 
The quality assessment of individual studies was done using the International 
Society for Pharmacoeconomics and Outcomes Research (ISPOR) Task Force 
Checklist for Quality Assessment of Retrospective Database Studies [30]. The 
assessment is presented in Table 13-3 in the Appendix. All the studies in-
cluded were assessed to be of very low quality. 
None of retrospective studies provided a rationale for the use of their respec-
tive study design, none developed an a priori data analysis plan, and only two 
studies recognized their study design as a potential limitation [23, 28] (one 
partially [24]). Furthermore, inclusion and exclusion criteria were clearly de-
scribed in three studies [24-26] and in only one study was the impact of study 
findings clearly described (in relation to eligibility criteria) [24]. With respect 
to the statistical models, only one study explained the rationale for the sta-
tistical method used and it was the same study that was also the only one 
that discussed how well their multivariate statistical techniques predict what 
was intended [24]. 
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Moreover, in none of the studies did the authors provide a theory for the find-
ings and ruled out other plausible explanations (except for [24]) and only two 
studies interpreted the statistical findings in terms of their clinical or eco-
nomical evidence [21, 24]. Limits to generalisability of the retrospective study 
results were recognised in three studies [23, 24, 28]. 
Overall the strength of evidence for the effectiveness and safety of MVSs in 
the day surgery setting was very low. No comparative prospective evidence 





Survival rates related to surgeon volume were reported at two, five, and ten 
years in one study [28]. Yearly volume rates ranges from low (<102), medi-
um (102-164), high (164-340), to very high (≥340). At two years after hip ar-
throscopy, survival rates were 86.5, 87.7, 94.6, and 97.6%, respectively. At 
five years, survival rates were 78.5, 82.7, 90.2, and 97.6% respectively. At ten 





With respect to surgeon volume, the cataract surgery (phacoemulsification) 
study reports for four surgeons that the number of cases per surgeon was in-
versely correlated with posterior capsule rupture (PCR) [22]. The surgeon 
with 411 total cases per year had a PCR and vitreous loss (VL) rate respective-
ly of 3.75%, the surgeon with 536 annual cases had a PCR/VL rate of 0.37%, 
the surgeon with 1,056 total cases had a PCR/VL rate of 0.28%, and the fourth 
surgeon with an annual case load of 1,336 had a PCR/VL rate of 0.29%. Over-
all, 23 of the 3,339 patients (0.68%) needed a revision surgery. Five of the 23 
patients did not have sufficient support to place a posterior chamber or sul-
cus intraocular cataract lenses (IOL) and required placement of anterior cham-
ber IOLs. 
Non-routine disposition at discharge 
The relationship between hospital/surgeon volume and patients’ health con-
dition after day surgery was reported in three studies through the outcome of 
non-routine disposition of patients at discharge [21, 25, 26]. Non-routine dis-
position includes re-admission including admission for 23-h observation, full 
admission (obs. longer than 24 hours), transfer to another hospital, skilled 
nursing facility, intermediate care facility, or home health care. Over the pe-
riod of four years, two studies report on the same curve that the higher the 
hospital/surgeon volume, the lesser the number of patients with non-routine 
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For the intervention of rotator cuff repair [25], ACL reconstruction [26], and 
meniscectomy [26], the surgeon volume rates ranged from low (<15/<25/<75), 
medium (15-30/25-75/75-175), to high (≥30/≥75/≥175), respectively. In case 
of rotator cuff repair, low and medium volume surgeons were 2.8 (CI 0.9-9.1) 
and 1.5 (CI 0.7-3.1) times more likely to have non-routinely disposed patients 
at discharge than high volume surgeons [25]. In case of ACL reconstruction, 
low and medium volume surgeons were 4.5 and 2.25 times more likely to have 
the same outcome compared to high volume surgeons [26]. And in case of 
meniscectomy, low and medium volume surgeons were 2.8 and 1.4 time more 
likely to have non-routinely disposed patients at discharge than high volume 
surgeons [26]. 
For the intervention of rotator cuff repair [25], ACL reconstruction [26], and 
meniscectomy [26], the hospital volume rates ranged from low (<75/<125/ 
<600), medium (75-200/125-300/600-1,200), to high (≥200/≥300/≥1,200), 
respectively. In case of rotator cuff repair, low and medium volume hospitals 
were 2.1 (0.6-8.0) and 1.7 (0.2-11.6) times more likely to have non-routinely dis-
posed patients at discharge than high volume hospital [25]. In case of ACL 
reconstruction, low and medium volume hospitals were 3.33 and 0.66 time 
more likely and in case of meniscectomy, low and medium volume hospitals 
were 8 and 6 time more likely to have nonrou-tinely disposed patients at dis-
charge than high volume hospitals [26]. 
For the intervention of outpatient thyroidectomy [21] in the low-surgical vol-
ume hospital, there were no re-admission in same-day surgery patients. One 
patient was discharged from the emergency room for symptoms of paraesthe-
sia with normal calcium levels. The surgeon volume amounted to ten thyroid 
surgical cases per year on average. The hospital volume averaged of 20 thyroid 
surgical cases per year. 
(Risk-adjusted) Incidence of postcataract surgery endophthalmitis 
For the intervention of cataract surgery (general) an inverse volume-response 
relationship was observed between endophthalmitis incidence and surgical 
volume [24]. The surgeon volume categories ranged from 1-50 (1), 51-200 (2), 
201-500 (3), 501-1,000 (4) and ≥1,001 (5). Surgeons in category (1) had an 
overall endophtalmitis rate per 1,000 surgeries (ERpT) of 2.57 with annual 
total endophthalmitis (TE) cases of 352. The overall ERpT surgeries in the 
categories (2), (3) and (4) were 1.49, 1.17 and 0.80 with TE cases of 1,1455, 
1,512 and 454. Surgeons in the category (5) had the lowest overall ERpT sur-
geries with 0.62 and 168 cases of TE. The difference in relative risk for en-
dophtalmitis was 4-fold (RR of 4.17) among surgeries performed by surgeons 
in category (1), completing between 1 and 50 surgeries per year, compared 
with surgeons in category (5) that served as the reference group, whose an-
nual volume was ≥ 1,000 surgeries. Surgeons in category (4), (3) and (2) had a 
relative risk of 1.30, 1.89 and 2.42 compared to the reference group (5). After 
adjusting for risk factors the RR in category (1) was still 3.8-fold higher than 
in the reference category (5). 
Mean operating time 
The outcome of mean operating time is reported here for its potential con-
nection with morbidity. Reported in the same studies with the same volume 
parameters as the outcome of disposition at discharge, mean operating time 
was reported with respect to both surgeon as well as hospital volume. The 
general trend remained that the higher the volume, the shorter the operating 
time. 
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With respect to surgeon volume, the rotator cuff study reports similar mean 
operating time for low and medium volume surgeons (112±4 and 113±4 min-
utes, respectively) and shorter time for high volumes surgeon (102±4 minutes 
with p<0.001) [25]. In case of ACL reconstruction, low and medium volume 
surgeons had a longer mean operating time (149±9 and 137±9 minutes, re-
spectively) compared to high volume surgeons (122±9 minutes) [26]. And in 
case of meniscectomy, low and medium volume surgeons had a longer mean 
operating time (72±6 and 64±6 minutes, respectively) compared to high vol-
ume surgeons (53±6 minutes) [26]. 
With respect to hospital volume, the rotator cuff study reports the same in-
verse relationship of mean operating time and volume. Low and medium vol-
ume centres had the mean operating time of 111 and 109 minutes, respec-
tively, while high volumes centres had 105 minutes [25]. In case of ACL re-
construction, low and medium volume hospitals had a longer mean operating 
time (150±9 and 132±9 minutes, respectively) compared to high volume sur-
geons (129±14 minutes) [26]. And similarly in case of meniscectomy, low 
and medium volume surgeons had a longer mean operating time (71±5 and 
66±6 minutes, respectively) compared to high volume surgeons (52±6 min-
utes) [26]. 
Progression, Recurrence, and Re-admission 
The relationship between hospital/surgeon volume and progression or recur-
rence of the health condition after day surgery was reported through the out-
comes of risk of reoperation (in one study [28]), hospital visit within 30 days 
of intervention (in one study [23]), and LOS (in one study [25]). 
Risk of reoperation was reported in the hip arthroscopy study with yearly 
volume rates ranging from low (<102), medium (102-164), high (164-340), to 
very high (≥340) [28]. Patients of surgeons with high annual case volumes 
had a lower risk of reoperation compared with those operated on by low vol-
ume surgeons. The hazard ratio for reoperation (with reference value of <102 
cases/year) was 0.90 (CI±0.74) for medium volume surgeons, 0.42 (CI±0.32) 
for high volume surgeons, and 0.17 (CI±0.07) for very high volume surgeons. 
Hospital based acute care within 30 days of surgery was reported in an ACL 
reconstruction study with 5 year-volume rates ranging from low (<100), me-
dium (100-500), to high (≥500) [23]. The odds ratio for hospital based acute 
care within 30 days (with reference value of <100 cases/5 years) was 0.77 (p 
0.059) for medium volume hospital and 0.47 (p <0.001) for high volume hos-
pitals. 
LOS was reported in the rotator cuff repair study in relation to both surgeon 
as well as hospital volumes where surgeon volume rates ranged from low 
(<15), medium (15-30), to high (≥30) and hospital rates ranged from low 
(<75), medium (75-200), to high (≥200) [25]. The LOS was 2.3 (CI 1.2-4.4) 
and 1.3 (0.7-2.6) times longer for low and medium volume surgeons that for 
high volume surgeons. And in terms of hospitals, LOS was 0.5 (0.2-1.1) and 
1.1 (0.4-3.1) time longer in low and medium compared to high volume hos-
pitals. 
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Health-related quality of life 
Outcomes related to disease specific quality of life and surgeon volume rates 
were reported in one carpal tunnel release study [27]. The two outcomes in 
question are reduction in pain score on VAS scale and mean BCTQ score. 
Surgeon yearly volume rates ranged from low (6-44 cases), medium (47-71 
cases), to high (75-163 cases). 
Regarding symptom severity score as well as functional status score, there 
was no relationship between surgeon volume and BCTQ score at six months’ 
follow-up. The scores were identical for all volume categories (1.7 points). 
Regarding pain score units on VAS scale, the comparison of baseline to six 
months’ follow-up showed no proof of the inverse VOR. While patients of low 
volume surgeons improved by 29 units, patient of medium volume surgeons 
by 31 units, and high by 32 units. 
 
Patient satisfaction 
No evidence was found to answer this research question. 
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9 Safety 
9.1 Outcomes 
The following outcomes were defined as crucial to derive a recommendation: 
 Serious adverse events (SAEs) 
Further outcomes considered were: 
 Day surgery related adverse events (AEs) (wound infection,  
wound dehiscence, major bleed ... etc.) 
 
 
9.2 Included Studies 
For the assessment of safety, eight studies met the inclusion criteria (same 
studies as described in the section of clinical effectiveness). Two of eight stud-
ies listed AEs [27, 28], while none listed SAEs. None of the studies reported 
on the relationship between SAEs/AEs and surgeon/hospital volume. 
Study characteristics and results of included studies are displayed in Table 





No evidence was found to answer this research question. The only safety re-
lated data reported were without its relationship to surgeon/hospital volume. 
In the hip arthroscopy study, 0.2% of patients experienced procedural com-
plication at 30 days post intervention – the complications were: myocardial 
infarction ileus, pneumonia, sepsis, mechanical complication, hardware fail-
ure, deep vein thrombosis/pulmonary embolism, wound infection, disloca-
tion/iatrogenic instability, major bleed [28]. In the carpal tunnel release study, 
1.6% of patients experienced procedural complications such as wound infec-
tions, wound dehiscence [27]. 
In the thyroidectomy study [21], 19 of the 160 patients experienced compli-
cations. Complications included transient hypercalcemia (5%), temporary vo-
cal cord paralysis (2.5%), post-operative seromas requiring aspiration (1.9%), 
post-operative hematoma requiring aspiration (1.25%), bilateral vocal cord 
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10 Discussion 
Clinical effectiveness and safety 
To our knowledge, this is the first systematic review on minimum volume 
standards (MVSs) applied to the general setting of day surgery. The 2012 
IQWiG report on effects of minimum volume regulations was set out to eval-
uate outpatient evidence only, however, it also included inpatient data [141]. 
Summary of evidence from retrospective database analysis 
We found no prospective or controlled trials for the analyses of clinical ef-
fectiveness and safety. We found eight retrospective database analyses on 
seven different indications, but none reported on the volume-outcome rela-
tionship (VOR) with respect to safety. Each indication included the follow-
ing number of patients: 
 thyroidectomy – 109 outpatient (and 51 inpatient) patients [21], 
 cataract surgery – 2,289,307 patients [22, 24] 
 primary hip arthroscopy – 7,836 patients [28], 
 open carpal tunnel release – 1,345 patients [27], 
 rotator cuff repair – 9,973 patients [25] 
 ACL reconstruction – 45,262 patients [23, 26] 
 and meniscectomy – 123,012 patients [26]. 
All interventions (except for carpal tunnel release and thyroidectomy) con-
firmed the hypothesis in favour of the VOR. None, however, established min-
imum volume standards for the respective interventions. 
Concerning thyroidectomy, there was no VOR observed, but it was suggested 
that thyroidectomy is safe also in low volume centers as in the single low vol-
ume center, no cases of readmission occurred [21]. 
Concerning cataract surgery, the number of cases per surgeon was inversely 
correlated with the adverse event of posterior capsule rupture (PCR) where 
PCR and vitreous loss (VL) rate were 3.75% for low volume and 0.29% for 
very high volume surgeons [22]. The difference in relative risk for endoph-
talmitis was 4-fold between low and very high volume surgeons [24]. 
Concerning hip arthroscopy, the survival rates for very high volume surgeons 
were 11.1-24.9% higher than for low volume and the hazard ratio for reoper-
ation (with reference value of low volume) was 0.17 for very high volume sur-
geons [28]. 
Concerning open carpal tunnel release, Boston Carpal Tunnel Syndrome Ques-
tionnaire (BCTQ) score did not vary with volume at all while the difference 
on the visual analogue scale (VAS) scale was 1 point (out of 100) between low 
and high volume surgeons (18 vs. 19 points) [27]. Such difference is below the 
threshold of the minimal clinically important difference [29]. 
Concerning rotator cuff repair, patients of low volume surgeons were 2.8 time 
more likely to have non-routine disposition at discharge, while low volume 
hospitals were 2.1 times more likely to discharge patients with non-routine 
dispositions. Surgeon-related mean operating time was 10 minutes shorter 
and hospital-related mean operating time was 6 minutes shorter for high vol-
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ume compared to low volume surgeons/hospitals. Length of stay (LOS) was 
2.3 times longer for low volume surgeons and 0.5 times for low volume hos-
pitals compared to high volume surgeons/hospitals [25].  
Concerning anterior cruciate ligament (ACL) reconstruction, the odds ratio 
for hospital based acute care within 30 days (with reference of low volume 
hospitals) was 0.47 for high volume hospitals [23]. Low volume surgeons were 
4.5 times more likely and low volume hospital 3.33 times more likely to have 
non-routinely discharged patients compared to high volume surgeons [26]. 
Furthermore, low volume surgeons had a 27 minutes longer and low volume 
hospitals 21 minutes longer mean operating time than high volume surgeons/ 
hospitals [26]. 
Concerning meniscectomy, low volume surgeons were 2.8 times and low vol-
ume hospitals were 8 times more likely to have non-routinely disposed patients 
at discharge than high volume surgeons/hospitals [26]. In terms of mean op-
erating time, both low volume surgeons and low volume hospitals had a longer 
mean operating time by 19 minutes compared to high volume surgeons/hos-
pitals [26]. 
Gaps in evidence 
While the VOR has some standing in the inpatient setting [44], it is argued 
that that relationship is based on low quality of evidence [142]. That is even 
more true for the day surgery setting and because of the fact that day surgery 
centres may operate independently from hospitals and so miss on the safety 
net in the form of emergency departments, quality assurance in day surgery 
is of even more importance. That places the extra emphasis on day surgery 
interventions to go well in the first place and hence also on quality assurance 
measures such as MVSs. 
Relevance of evidence 
Due to these gaps in evidence, the relevance of the current evidence base to 
relative effectiveness assessment of MVSs is questionable. Retrospective da-
tabase analyses do not fulfil the evidence-based medicine standards as they 
are prone to a spectrum of biases. For that reason, their conclusions are ap-
plicable only in part. In their favour plays the relatively robust body of evi-
dence from the inpatient setting, relatively high number of patients included 
in the day surgery studies, and studies supporting no significant difference 
in outcomes between the settings [3]. Against it plays the poor internal and 
external validity of the present evidence base and the critical considerations 
related to MVSs in general. 
Internal and external validity of the present evidence base 
Concerning effectiveness and safety of MVSs, the quality of the evidence 
base is very low. The main reasons are the retrospective design of all the 
studies [21-28], the lack of justification for its use [21, 22, 25-27], or the lack 
of a priori data analysis plan [21-28]. Further reasons include unclear eligi-
bility criteria [21-23, 27, 28], lack of justification for the statistical models 
used [21-23, 25-28], lack of interpretation of the statistical findings in terms 
of their clinical or economical evidence [22, 23, 25-28], and limited recogni-
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Moreover, the validity of the endpoints used is also questionable. None of 
the safety endpoints were reported in relation to surgeon or hospital volumes, 
only one study reported on a mortality endpoint [28], three on morbidity 
endpoints [23, 25, 26], one on disease specific QoL endpoint [27], and none 
of patient satisfaction. Day surgery related outcomes such as frequency of 
hospital infections or venous thrombosis embolisms were not reported in any 
of the studies.  
External validity of the data for the sake of establishing MVSs in the Austri-
an context is questionable as well. Even though the conclusions of all the in-
cluded studies are based on clinical practice data, the potential patient selec-
tion bias or the retrospective study design and the questionable generalisa-
bility undermine the external validity. Generalsiability of the data is put in 
question because all the studies (except for [27]) were conducted in the USA 
where the definition of day surgery and outpatient surgery may vary [20].  
 
Critical considerations and contradictory evidence 
A critical synthesis has to be made to draw attention on the complexity of 
the VOR and thereof derived administrative MVSs. It is crucial to consider 
the over deterministic nature of this relationship in order to avoid possible 
methodological drawbacks in the study design and to guarantee explanatory 
power [8, 143]. 
Without a doubt, taking into account risk-adjustment and case mix is imper-
ative as the first step toward getting unbiased estimates of the effect of vol-
ume on outcome, but volume of surgeries can only be a proxy for higher qual-
ity. Halm et al. point out that besides general methodical shortcomings, stud-
ies investigating the VOR were not able to determine what surgical abilities 
or management skills of the surgery unit are enhanced by volume and why 
they should be uniquely related to volume [107]. Whether high-quality hospi-
tals or surgeons are more likely to be sought by patients in the first place 
and are therefore capable of accumulating a higher-volume is also important 
to consider. Word of mouth takes a substantial part in the decision of where 
to undergo treatment that is often neglected in studies and health care re-
search [95]. Also the question whether patients of high-volume providers are 
more likely to be selected into treatment by the provider compared to low-
volume surgeons or hospitals is mainly unanswered [107]. 
When conducting volume-outcome analysis, one has to be cautious not to fall 
in a mono-causal or reverse causality trap when establishing links between 
two or more variables. An observed correlation does not necessarily indicate 
causation. Against this backdrop, it is important to synthesise the various ap-
proaches to emphasise the complexity of the VOR and its derived policies. 
The two approaches – practice makes perfect and selective-referral – imply sig-
nificantly different policy choices [8]. While the practice makes perfect hypo-
thesis gives reasonable arguments to implement a (regulatory) framework in 
the form of MVSs, the selective referral approach would indirectly appeal to 
healthcare research to understand why phenomena such as centralisation of 
services in form of volume accumulation of a few hospitals came up in the 
first place. 
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A scientific and surgery specific examination of the study situation is neces-
sary to establish evidence-based minimum quantities. Quality is influenced 
by other factors such as the application of the best treatment methods. These 




The evidence base found was only partly relevant for answering the research 
questions. The retrospective study design can at best show correlations be-
tween surgeon/hospital volumes and day surgery outcomes, however, its re-
sults are of limited certainty and none of the studies answered the question 
on the threshold MVSs. 
In the systematic literature search, we only found VOR data on eight interven-
tions, which, however, is not a representative sample of all the interventions 
eligible for day surgery.  
Also, the consistency of definitions of the included studies is questionable. 
The reason is that the US’ use of the term day surgery may include 23 hour 
stay surgery, which in the EU is seen as an inpatient surgery with a one day 
LOS. 
Furthermore, the following studies on arthroscopy, meniscal repair, and co-
lonoscopy [31-33] were excluded from the analysis even though they met the 
inclusion criteria. The reason was that they were found in an additional search 
in the end stage of the report when including them was no longer feasible. 
Additional reason for not including them was their assumed low marginal 
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11 Conclusion 
The need for a shift of surgical interventions from the inpatient setting to the 
day surgery setting is advocated in the international literature. The reasons 
for the shift include organisational, ethical, economic, and medical aspects 
and quality assurance in the process is argued to be key. Because the VOR 
does have some standing in the inpatient setting, the role of MVSs applied to 
the day surgery setting was scrutinised in this report. Surely, identifying pos-
sible analogies between the inpatient and the day surgery settings can serve 
as a valuable decision-making foundation, however, the lack of evidence of 
clearly established MVSs, methodical issues, and the different nature of in-
patient and day surgery settings make the simple transition of inpatient re-
sults to the day surgery setting questionable. Hence, we discussed the theo-
retical explanations of the quantity-quality relationship and the thereof de-
rived reasons for implementing MVSs. Besides the above theory of MVSs, we 
aimed to provide the data on international variations and current use of MVSs 
with a particular focus on the German context.  
There is no consensus behind the theory of MVSs and also the results from 
our systematic review cannot offer any clear-cut MVS thresholds. This pre-
sent report, however, provides some evidence in favour of VOR, even though 
it based on low quality retrospective data-analyses. The low quality of the re-
trospective evidence found does not establish the clear presence of the VOR 
nor any clear MVSs. Two out of eight studies did not suggest a VOR at all and 
the generalisability of the results is questionable because seven out of eight 
studies were conducted in the US context. For these reasons, we argue that 
the application of MVSs should be well thought out. Moreover, because es-
tablishing the VOR and henceforth the MVSs is possible, quality prospective 
controlled evidence for the day surgery setting is required. Also, other quality 
assurance standards such as standards focusing on process and outcome quali-
ty should be taken into account. 
In terms of adequate policy implications, if optimal surgery specific MVSs 
can be established as a quality standard and it is secured by a high-quality 
body of evidence for the VOR, then it is also indispensable to derive an appro-
priate public policy to disseminate this information to payers, health care 
consumers, and clinicians. Prima facie, there are three different policy ap-
proaches: (1.) utilising the data on volumes and outcomes to enhance perfor-
mance, (2.) adopting measures to limit the number of hospitals or ambulato-
ry care units permitted to conduct only a certain set of procedures, and (3.) 
publication or dissemination of the data on volume. 
All these aspects are crucial to consider, not only to assure compliance with 
MVSs and subsequently to assure the intended quality of outcome, but also 
to establish transparency in the health care system by providing relative per-
formance data between and within healthcare organisations. It is important 
that not only professional bodies, hospitals, and surgeons conducting day sur-
gery should be obliged to assure evidence based quality standards by im-
plementing, complying, and monitoring any deviations, but also institutions 
within the health care system responsible for nationwide health care planning 
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13.1 Evidence tables of individual studies included for clinical effectiveness and safety 
Table 13-1: Results from retrospective database analyses (joints and carpal tunnel) 
 Degen et al. [28] (2017) Evers et al. [27] (2018) Jain et al. [25] (2005) Jain et al. [26] (2004) Liu et al. [23] (2018) 
Country USA The Netherlands USA USA USA 
Sponsor National Institute of Health/ 
National Institute for Arthritis 
and Musculoskeletal and Skin 
Diseases (R01AR066069) 
National Institute of Health/ 
National Institute of Arthritis 
and Musculoskeletal and Skin 
Diseases (RO1 AR82813) 
NA NA NA 
COI 1 author ( B.T.K) has COI due 
to fees form Arthrex and  
A-3 surgical 
None NA NA None 
Study design Retrospective database 
analysis of 137 surgical centres 
(multivariate regression) 
Retrospective database analysis 
of 11 surgical centres (univariate 
and multivariate regression) 
Retrospective database 
analysis of unclear 




analysis of unclear number of 
surgical centres (multivariate 
logistic and linear regression) 
Retrospective database 
analysis of unclear number 
of surgical centres 
(multivariate regression) 
Conducted in 1998-2012 2011-2015 1997-2000 1997-2000 2009-2013 
Indication Hip arthroscopy Carpal tunnel syndrome See inclusion criteria 
below 
See inclusion criteria  
below 
Anterior cruciate ligament 
injury 
Intervention Primary hip arthroscopy Open carpal tunnel releases Rotator cuff repair ACL reconstruction & 
Meniscectomy 
ACL reconstruction 
Setting Outpatient Outpatient Outpatient Outpatient Outpatient 
Type of volume analysis 
(surgeon/hospital) 
Surgeon Surgeon Surgeon & hospital Surgeon & hospital Hospital 
Comparator NA NA NA NA NA 
Number of pts  7,836 2,05710 10,93411 ACL: 32,440 
Men: 195,59712 
26,873 
Number of procedures 8,26713 2,057 NA NA NA 
                                                             
10 1,345 pts included in the analysis. 
11 Number of pts finally included in the analysis was 9,973. Exclusion criteria were applied to exclude diagnoses, which outcomes were expected to differ from outcomes of the included indications. 
12 Number of pts finally included in the analysis was 18,390 for ACL and 123,012 for meniscectomy. 
































 Degen et al. [28] (2017) Evers et al. [27] (2018) Jain et al. [25] (2005) Jain et al. [26] (2004) Liu et al. [23] (2018) 
Number of surgeons  295 17 NA NA NA 
Number of hospitals 137 11 NA NA NA 




 Very high 
<102 
102 ≤ x < 164 


































Operating time, median 
in min (range) 
NA NA 102 (30-595)17 ACL: 125 (NA) 
Men: 55 (NA) 
NA 
Inclusion criteria HA for diagnosis with or 
without synoval biopsy, HA 
for removal of loose/foreign 
body, HR & chondroplasty, 
abrasion arthroplasty & 
resection of labrum, HA & 
synovectomy, HA with femo-
roplasty, HA with acetabulo-
plasty, HA with labral repair, 
total hip replacement, re-
surfacing hip & partial/total 
acetabulum & femoral head 
Consent, primary carpal tunnel 
release, baseline and follow-up 
measurement of BCTQ 
Rupture of the rotator 
cuff, disorders of bursae 
and tendon, sprains and 
strains of the rotator cuff 
capsule 
ACL: Complete rupture of old 
disruption of ACL and sprain of 
cruciate ligament of the knee 
Men: derangement, bucket 
handle tear, simple tear of the 
meniscus or cartilage 
NA 
Exclusion criteria NA Unavailable operative report, 
unidentified surgeon, cases in 
which surgeons did not perform 
CTRs for at least 1 year within 
the cohort 
Shoulder bone infection, 
present surgery as 
corrective surgery, 
malignancy, pathologic 
fracture, fracture due to 
injury in the bones of the 
shoulder region, or 
simultaneous total or 
partial shoulder 
arthroplasty 
ACL/Men: Lower leg bone 
infections like osteomyelitis, 
inflammatory reaction due to 
graft, correction surgery, 
malignancies or pathological 
fractures, fractures due to injury, 
simultaneous knee arthroplasty, 
rheumatoid arthritis, operating 
time <45 min & <20 min in  
case of meniscectomy 
Non-New York residents, 
pts that left against 
medical advice, mortalities, 
pts  
<18 yrs, surgeries from 
December 2013 
                                                             
14 Number of cases in the period of 1997-2000. 
15 Number of cases per 4 years. 
16 Number of cases per 5 years. 

















 Degen et al. [28] (2017) Evers et al. [27] (2018) Jain et al. [25] (2005) Jain et al. [26] (2004) Liu et al. [23] (2018) 
Co-interventions NA Trigger finger release, cubital 
tunnel relese, Guyon release, 
radial tunnel release, fasciotomy 
Dupuytren, other, standard 
postoperative care – nerve and 
tendon-gliding exercises 
NA NA NA 
Age, mean, yrs (range) 38 (7-84) 54 (41-67) 56 (43.6-68.4) ACL: 29.4 (18.9-39.9) 
Men: 47.3 (31.9-62.7) 
Average 33.3 (22.0-46.6) 
Sex, female:male, n 4,443:3,801 986:359 3,785-6,188 ACL: 7,481: 10,90818 
Men: 50,108:72,88919 
9,811:17,049 
BMI±SD NA 27 ± 5 NA NA NA 
Comorbidities NA Diabetes mellitus, Rheumatoid 
arthritis, Dupuytren’s disease, 
Trigger fingers, CMCI joint 
arthritis, compression neuro-
pathy, tendinitis, history of wrist 
trauma, scaphotrapeziotrapezoidal 
joint arthritis, radiocarpal 
arthritis, peripheral neuropathy, 
cervical radioculopathy, 
ulnocarpal impingement 
Mean Deyo score: 0.1-0.9 NA Mean Deyo score: 0.06 
Follow-up time, yrs 1020 0.5 NA NA 30 days 
Patients excluded from 
the analysis, n (%) 













NA NA NA NA 
                                                             
18 Records missing on 1 pt.  
19 Records missing on 15 pts.. 































 Degen et al. [28] (2017) Evers et al. [27] (2018) Jain et al. [25] (2005) Jain et al. [26] (2004) Liu et al. [23] (2018) 




 P value 




NA NA NA 
BCTQ, mean n      
 Symptom severity score 
 Functional status score 
NA 
NA 
Low&Medium&High: all 1.722 







Hospital based acute care within 30 days, odds ratio n at 5 years (p value)    
 Low volume  
 Medium volume 














0.77 (p 0.059) 
0.47 (p <0.001) 
Risk of reoperation, hazard ratio n (95% CI)     
 Low volume 
 Medium volume 
 High volume 
 Very high volume 
x 
0.9x (CI-0.74) 
0.42 (CI 0.32) 

















Non-routine disposition of pts at discharge23, surgeon, n (95% CI)    
 Low volume 
 Medium volume 










ACL: 0.9% Men: 1.4% 
ACL: 0.4% Men: 0.7% 




Non-routine disposition of pts at discharge, hospital, n (95% CI)    
 Low volume 
 Medium volume 










ACL: 1% Men: 1.6% 
ACL: 0.2% Men: 1.2% 




                                                             
21 The scores were reported only in a table and so the following numbers are only authors’ estimates. 
22 The scores were reported only in a graph and so the following numbers are only authors’ estimates. 
23 Non-routine disposition included transfer to another hospital, skilled nursing facility, intermediate care facility, or home health care. Routine disposition reflected patients  

















 Degen et al. [28] (2017) Evers et al. [27] (2018) Jain et al. [25] (2005) Jain et al. [26] (2004) Liu et al. [23] (2018) 
Mean operating time volume, surgeon, min (±SD)     
 Low volume 
 Medium volume 
 High volume 













ACL: 149(9) Men: 72(6)24 
ACL: 137(9) Men: 64(6) 






Mean operating time volume, hospital, min (±SD)     
 Low volume 
 Medium volume 










ACL: 150(9) Men: 71(5)24 
ACL: 132(9) Men: 66(6) 




LOS and surgeon volume, n (95% CI)     
 Low volume 
 Medium volume 
















LOS and hospital volume, n (95% CI)     
 Low volume 
 Medium volume 

















SAE NA NA NA NA NA 
AEs, n (%) 
 Day surgery related 
AEs 
NA (0.2)25 
MI, ileus, pneumonia, sepsis, 
mechanical 
complication, hardware failure, 
DVT/PE, wound infection, 
dislocation/iatrogenic 
instability, major bleed26 
23 (1.6) 








ACL – Anterior cruciate ligament, BCTQ – Boston Carpal Tunnel Questionnaire, COI – conflict of interests, CTR – carpal tunnel release, DVT – deep vein thrombosis, ED – emergency 
department, HA – hip arthroscopy, LOS – length of stay, THA – total hip arthroplasty, Men – Meniscectomy, MI – myocardial infarction, NA – Not available, PE – pulmonary embolism  
 
                                                             
24 Only restricted to the New York state database pts. 
25 30 days procedural complication rate. 
26 Not reported in what n of pts, nor in relationship to surgeon volume. 
































Table 13-2: Results from retrospective database analyses (thyroid and cataract surgery) 
 Ayala and Yencha [21] (2015) Chen et al. [22] (2014) Keay et al. [24] (2012) 
Country USA USA USA 
Sponsor NA NA National Eye Institute: R01EY016769. K.K funded 
by an Australian National Health and Medical 
Research Council post-doctoral fellowship. 
E.W.G. recipient of an Ernest and Elizabeth 
Althouse Special Scholar’s Award from Research 
to Prevent Blindness. 
Conflict of Interest One author (Yencha) was involved in all 
cases either as primary or assistant surgeon 
None None 
Study design Retrospective single centre analysis Retrospective single centre chart 
review 
Retrospective analysis of Medicare beneficiary 
claims data 
Conducted in 2006-2014 2011-2012 2003-2004 
Indication Benign or malignant thyroid carcinoma Cataract Cataract 
Intervention Outpatient thyroid surgery/Thyroidectomy Cataract Surgery (Phacoemulsification) Cataract Surgery 
Setting Outpatient and Inpatient28 Outpatient Surgical Centre Outpatient surgery centres 
Type of volume analysis (surgeon/hospital) Surgeon & Hospital Surgeon Surgeon 
Comparator Inpatient Thyroid surgery/Thyroidectomy NA NA 
Number of pts, I vs C 160 (109 vs 51)29 3,339 2,285,96830 
Both eyes: 1,005,826 (44%) 
One eye: 1,280,14230 (56%) 
Number of procedures, I vs C31 Total: 35 vs 26 
Hemi: 62 vs 20 
Completion: 11 vs 5 
NA 3,280,96632 
                                                             
28 Patient who were eligible for same day discharge were observed typically for 2–4 h. Patients with significant co-morbidities, lack of social support,  
and/or patients not comfortable with outpatient recovery were admitted for observation. 
29 43 pts were kept for 23 h observation and 17 (40%) of these patients were found to have social factors requiring an overnight stay  
(due to long distance, absence of responsible adult caregiver); remaining 26 pts requiring a 23 h observation had significant co-morbidities. 
30 Own calculation on the basis of the given numbers of patients (absolute and relative) with surgery on both eyes. 
31 Outpatient (Intervention) vs Inpatient (Comparator) 
32 35,068 surgeries could not have been attributed to a specific surgeon and also contain surgeries for which surgeon characteristics data were missing.  

















 Ayala and Yencha [21] (2015) Chen et al. [22] (2014) Keay et al. [24] (2012) 
Number of surgeons  NA 4 11, 87333 
Number of hospitals 1 1 NA 
Surgeon/Surgeon volume categories,  
n (cases/year) 
Unclear34 Surgeon 4: 411 
Surgeon 1: 536 
Surgeon 2: 1,056 






Hospital volume categories, n (cases/year) Unclear NA NA 
Operating time, median in min (range) NA NA NA 
Inclusion criteria Patients in ASA class 
1,2,3 and 4 
Use of topical anaesthesia and 
performance of the intervention at an 
outpatient centre/setting 
Patients with max. 2 cataract surgeries per 
beneficiary during the 2-year study timeframe; 
Medicare beneficiaries ≥65 years 
Exclusion criteria NA Patients requiring additional 
anaesthesia and those who were 
operated on in a hospital setting 
Records were excluded if data indicated the 
surgery was not performed, the procedure was a 
return to the operating room for a related 
procedure or due to data coding issues; surgeries 
performed in the last 42 days of 2004 
ASA class, n, I vs C 1 and 2: 90 vs 39 
3 and 4: 19 vs 12 
NA NA 
Co-interventions Intravenous dexamethasone, intravenous 
antibiotics, anaesthesia at surgeon’s discretion, 
Prophylactic calcium carbonate and vitamin D 
(calcitriol) supplementation for pts 
undergoing total or completion thyroidectomy 
NA NA 
Age, mean, yrs (range) [SD] 41.8 (14-75)/47.8 (19-77) 73 (60-86) [3] NA (≥6535) 
Sex, female:male, n, I vs C 82:27 vs 25:26 13:10 NA 
BMI±SD NA NA NA 
                                                             
33 Own calculation on the basis of the descriptive statistics of the endophthalmitis rate by annual Medicare surgical volume found in Table 4. 
34 Thresholds for MVS classification (i.e. low, medium, high) is not clear. 
































 Ayala and Yencha [21] (2015) Chen et al. [22] (2014) Keay et al. [24] (2012) 
Risk Adjustment NA NA Age (65-74, 75-84, ≥85 
Gender, Race, Year, 
Ambulatory surgery centre (No, Yes),  
Surgeon experience in yrs (1-10, 11-20, 21-30, ≥30) 
Other influencing factors  
(Comorbidities etc.), n (%) 
NA Shallow chamber: 8 (35); 
Miosis: 7 (30); Restlessness: 6 (26); 
Floppy Iris: 6 (26); 
Pseudoexfoliation: 5 (22); 
Zonular dehiscence: 5 (22); 
Small eye: 1 (4) 
NA 
Patients excluded from the analysis, n (%) NA NA 165,452 and 35,06836 
Efficacy 
Revision Surgery NA 2337 of 3,339 NA 
Re-admission38, n (%), I vs C 039 vs NA NA NA 
Surgical volume,  
n (cases/year) – Risk of AE related  
to surgery 
NA 411 – 3.75; 
536 – 0.37; 
1 056 – 0.28; 
1 336 – 0.29 
PCR in 23 (0.68) in total 






Overall Endoph. Rate/1,000 surgeries40 (95% CI): 
1-50: 2.57 (2.30-2.83); 
51-200: 1.49 (1.42-1.57); 
201-500: 1.17 (1.11-1.23); 
501-1000: 0.80 (0.73-0.88); 
≥1001: 0.62 (0.52-0.71) 
                                                             
36 165,452 Surgeries performed in the last 42 days in 2004 were excluded and in the analysis of the endophthalmitis rate by annual medicare surgical volume 35,068 surgeries  
with unique physician identification numbers that cannot be attributed to a specific surgeon and surgeries for which surgeon characteristics data were missing. 
37 5 of the 23 patients did not have sufficient support to place a posterior chamber or sulcus intraocular cataract lenses (IOL) and required placement of anterior chamber IOLs. 
38 Re-admission includes admission for 23-h observation or full admission (observation longer than 24 h) 
39 One pt. was discharged from the ER for symptoms of paresthesias with normal calcium levels. 

















 Ayala and Yencha [21] (2015) Chen et al. [22] (2014) Keay et al. [24] (2012) 
Surgical volume,  
n (cases/year) – Risk of AE related  
to surgery 
(continuation) 
  PCR: Unadjusted RR (95% CI): 
1-50: 4.17 (3.47-5.01); 
51-200: 2.42 (2.06-2.84); 
201-500: 1.89 (1.61-2.22); 
501-1000: 1.30 (1.09-1.55); 
≥1001: 1.00 (Reference) 
Adjusted RR: (95% CI): 
1-50: 3.80 (3.13-4.61); 
51-200: 2.32 (1.97-2.74); 
201-500: 1.84 (1.56-2.17); 
501-1000: 1.30 (1.09-1.56); 
≥1001: 1.00 (Reference) 
Safety 
SAE NA NA NA 
AEs, Volume, n (%), 19 pts of 160 pts (11,90%)41 
Transient hypercalcemia: 5%; 
Temporary vocal cord paralysis: 2.5%; 
Bilateral vocal cord paralysis: 0.63% 
Inadvertent transection of the RLN: 0.63%; 
Post-operative seromas requiring aspiration: 
1.9%; 
Post-operative hematoma requiring 
aspiration: 1.25% 
NA NA 
NA – Not available, PCR – Post Cataract Endophthalmitis, SDS – same day surgery, SDT – same-day thyroidectomy, TE – Total Endophthalmitis, TT – Thyroidectomy,  
RLN – recurrent laryngeal nerve, RR – Relative Risk 
  
                                                             
































13.2 Quality assessment checklist  
Table 13-3: ISPOR Task Force Checklist for Quality Assessment of Retrospective Database Studies [30] 
Study  
reference/ID 
Degan et al. 
[28] (2017) 
Evers et al. 
[27] (2018) 
Jain et al.  
[25] (2005) 
Jain et al.  
[26] (2004) 





Chen et al.  
[22] (2014) 
Keay et al.  
[24] (2012) 
1. Relevance: Have the data attributes been described in sufficient detail 
for decision makers to determine whether there was a good rationale for 
using the data source, the data source’s overall generalisability, and how 
the findings can be interpreted in the context of their own organisation? 
Yes Yes Yes Yes Yes Yes Yes Yes 
2. Reliability and Validity: Have the reliability and validity of the data been 
described, including any data quality checks and data cleaning procedures?  
No Yes Yes Yes No No Yes Yes 
3. Linkages: Have the necessary linkages among data sources and/or 
different care sites been carried out appropriately, taking into account 
differences in coding and reporting across sources? 
Yes NA Yes Yes Yes NA42 NA42 Yes 
4. Eligibility: Have the authors described the type of data used to 
determine member eligibility? 
Yes Yes Yes Yes Yes No No Yes 
5. Data analysis plan: was a data analysis plan, including study hypotheses, 
developed a priori? Was the study conducted prospectively? 
Partial43 Partial43 Partial43 Partial43 Partial43 No44 No Partial43 
6. Design selection: has the investigator provided a rationale for the 
particular research design? 
No No No No No No No Partial45 
7. Research design limitations: did the author identify and address 
potential limitations of that design? 
Yes No No No Yes No No Partial 
8. Treatment effect: for studies that are trying to make inferences about 
the effects of an intervention, does the study include a comparison 
group and have the authors described the process for identifying the 
comparison group and the characteristics of the comparison group as 
they relate to the intervention group? 
NA NA NA NA NA NA NA NA 
9. Sample selection: have the inclusion and exclusion criteria and the steps 
used to derive the final sample from the initial population been described? 
Partial46 Partial47 Yes Yes Partial48 No Partial47 Yes 
                                                             
42 Single data source 
43 It is indicated in the text that a hypothesis was created a priori, but no more information is revealed. 
44 It is not explicitly stated in the text that a hypothesis was created a priori. 
45 They state that population-based studies can be generalised to the community more easily than center-specific studies because they represent the broad range  




















Degan et al. 
[28] (2017) 
Evers et al. 
[27] (2018) 
Jain et al.  
[25] (2005) 
Jain et al.  
[26] (2004) 





Chen et al.  
[22] (2014) 
Keay et al.  
[24] (2012) 
10. Eligibility: are subjects eligible for the time period over which 
measurement is occurring? 
NA NA NA NA NA NA NA NA 
11. Censoring: were inclusion/exclusion or eligibility criteria used to address 
censoring and was the impact on study findings discussed? 
Partial49 Partial49 Partial49 Partial49 Partial49 No Partial49 Yes 
12. Operational definitions: are case (subjects) and end point (outcomes) 
criteria explicitly defined using diagnosis, drug markers, procedure codes, 
and/or other criteria? 
Yes Yes Yes Yes Yes Partial50 Yes Yes 
13. Definition validity: have the authors provided a rationale and/or 
supporting literature for the definitions and criteria used and were 
sensitivity analyses performed for definitions or criteria that are 
controversial, uncertain, or novel? 
NA NA NA NA NA NA NA NA 
14. Timing of outcome: is there a clear temporal (sequential) relationship 
between the exposure and outcome? 
NA NA NA NA NA NA NA NA 
15. Event capture: are the data, as collected, able to identify the 
intervention and outcomes if they actually occurred? 
Yes Yes Yes Yes Yes Yes Yes Yes 
16. Disease history: is there a link between the natural history of the 
disease being studied and the time period for analysis? 
NA NA NA NA NA NA NA NA 
17. Resource valuation: for studies that examine costs, have the authors 
defined and measured an exhaustive list of resources affected by the 
intervention given the perspective of the study and have resource  
prices been adjusted to yield a consistent valuation that reflects the 
opportunity cost of the resource? 
NA NA NA NA NA NA NA NA 
18. Control variables: if the goal of the study is to examine treatment 
effects, what methods have been used to control for other variables 
that may affect the outcome of interest? 
Yes Yes Yes Yes Yes None51 None52 Yes 
                                                                                                                                                                                                                                                                                   
46 Only inclusion criteria were described. 
47 The inclusion/exclusion criteria were described only in part. 
48 Only exclusion criteria were described. 
49 Criteria were mentioned, but the impact on findings was not discussed. 
50 No explicit procedure codes were used. 
51 Only bivariate statistical analyses were conducted – no multivariate regression model was applied. 


































Degan et al. 
[28] (2017) 
Evers et al. 
[27] (2018) 
Jain et al.  
[25] (2005) 
Jain et al.  
[26] (2004) 





Chen et al.  
[22] (2014) 
Keay et al.  
[24] (2012) 
19. Statistical model: have the authors explained the rationale for the 
model/statistical method used? 
No No No No No Partial53 No Yes 
20. Influential cases: have the authors examined the sensitivity of the 
results to influential cases? 
NA NA NA NA NA NA NA NA 
21. Relevant variables: have the authors identified all variables hypothesised 
to influence the outcome of interest and included all available variables 
in their model? 
Yes Yes Yes Yes Yes No54 No No 
22. Testing statistical assumptions: do the authors investigate the validity 
of the statistical assumptions underlying their analysis? 
Yes Yes Yes Yes Yes No No No 
23. Multiple tests: if analyses of multiple groups are carried out, are the 
statistical tests adjusted to reflect this? 
NA NA NA NA NA NA NA NA 
24. Model prediction: if the authors utilise multivariate statistical techniques 
in their analysis, do they discuss how well the model predicts what it is 
intended to predict? 
No No No No No NA NA Yes 
25. Theoretical biases: have the authors provided a theory for the findings 
and have they ruled out other plausible alternative explanations for the 
findings? 
Partial55 Partial55 Partial55 Partial55 Partial55 Partial55 No Yes 
26. Practical versus statistical significance: have the statistical findings been 
interpreted in terms of their clinical or economic relevance? 
No No No No No Yes Partial56 Yes 
27. Generalisability: have the authors discussed the populations and 
settings to which the results can be generalised?  
Partial57 No No No Partial57 No No Yes 
Overall level of quality         
 
 
                                                             
53 Reasons for using the conducted statistical tests were given 
54 Only a low volume hospital with outpatient thyroidectomy was the object of analysis 
55 The authors did not rule out other possible interpretations. 
56 Authors refer only to one paper that also tests the respective hypothesis. 
57 It is stated that the current results are of limited generalisability. 
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13.3 Applicability table 
Table 13-4: Summary table characterising the applicability of a body of studies 
Domain Description of applicability of evidence 
Population The appropriate patient population was not pre-defined before the systematic search, but 
was identified through the iterative process of finding the indications/interventions for 
which the volume-outcome relationship and/or MVSs are documented. Generalisabiliy of the 
patient population is undermined as seven out of eight studies included for the analysis were 
conducted in the US context, while one was conducted in the Netherlands.  
Intervention The eight studies included report on seven different interventions. The retrospective study 
design provids real world data on the following interventions: primary hip arthroscopy, open 
carpal tunnel release, rotator cuff repair, ACL reconstruction, meniscectomy, throid surgery/ 
thyroidectomy, cataract surgery (phacoemulsification). None of the studies provide clear MVSs. 
Comparators We defined comparators as the same or comparable surgical interventions in the day surgery 
setting without minimum volume standards implemented. No studies with such comparators 
were found. 
Outcomes In principle, each study reported on a different set of outcomes. The outcomes that we 
considered crucial were relating volume data to mortality, morbidity, quality of life, and 
satisfaction outcomes. One study reported on the mortality outcome of survival, one on 
quality of life outcomes of pain on the VAS scale and BCTQ score, and none on satisfaction. 
Six studies reported on morbidity outcomes of hospital based acute care within 30 days, risk 
of reoperation, non-routine disposition of patients at discharge, mean operating time, and 
LOS. Three studies reported on AEs. 
Setting Because seven out of eight studies were conducted in the US context, the appropriateness  
of the setting is put into question. The reason is that in the US context, outpatient care/day 
surgery is not always defined in the same way as it is in the European context. The potential 
challenge is that the US’ use of the term day surgery includes 23 hour stay surgery, which in 
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13.4 Literature search strategies 
13.4.1 Search strategy for Cochrane 
Search Name: Minimum Volume Standards 
Search Date: 12/07/2019 
ID Search 
#1 MeSH descriptor: [Hospitals, High-Volume] explode all trees 
#2 MeSH descriptor: [Hospitals, Low-Volume] explode all trees 
#3 (volume NEXT outcome):ti,ab,kw (Word variations have been searched) 
#4 ("minimum volume* standard*") (Word variations have been searched) 
#5 (fallzahl*) (Word variations have been searched) 
#6 (mindestfallzahl*) (Word variations have been searched) 
#7 ((surgeon* OR surgic* OR surger*) NEXT volume*):ti,ab,kw 
#8 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 
#9 MeSH descriptor: [Ambulatory Surgical Procedures] explode all trees 
#10 MeSH descriptor: [Outpatient Clinics, Hospital] explode all trees 
#11 ((ambula* OR outpatient* or day*)) (Word variations have been searched) 
#12 #9 OR #10 OR #11 
#13 #8 AND #12 with Cochrane Library publication date Between Jan 2000 and Jul 2019 (Word variations have 
been searched) 
#14 #8 AND #12 with Publication Year from 2000 to 2019, in Trials (Word variations have been searched) 
#15 #13 OR #14 (Word variations have been searched) 
Total: 62 Hits 
 
13.4.2 Search strategy for CRD 
Search Name: Minimum Volume Standards 
Search Date: 12/07/2019 
ID Search 
#1 (minim* volume* standard*) 
#2 (volume-outcome) 
#3 ((surgeon* OR surgic* OR surger* OR hospital* OR procedur*) NEXT (volume* OR case-load* OR caseload*)) 
#4 #1 OR #2 OR #3 
#5 (ambula* OR outpatient* OR day*) 
#6 MeSH DESCRIPTOR Ambulatory Surgical Procedures EXPLODE ALL TREES 
#7 MeSH DESCRIPTOR Outpatient Clinics, Hospital EXPLODE ALL TREES 
#8 MeSH DESCRIPTOR Outpatients EXPLODE ALL TREES 
#9 #5 OR #6 OR #7 OR #8 
#10 #4 AND #9 
#11 (#10) FROM 2000 TO 2019 
Total: 24 Hits 
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13.4.3 Search strategy for Medline 
Search Name: Minimum Volume Standards 
Search Date: 12/07/2019 
ID Search 
#1 exp *Hospitals, High-Volume/(1087) 
#2 exp *Hospitals, Low-Volume/(654) 
#3 (volume adj outcome).ti,ab. (806) 
#4 ((surgeon* or surgic* or surger* or hospital* or procedur* or case or minim*) adj (volume* or case-load* or 
caseload*)).ti,ab. (8048) 
#5 1 or 2 or 3 or 4 (8866) 
#6 exp Ambulatory Surgical Procedures/(12921) 
#7 exp Outpatient Clinics, Hospital/(17805) 
#8 surgery.fs. (2161180) 
#9 9 and 10 (397) 
#10 ((ambulatory* or outpatient* or day*) adj3 (surge* or surgic* or procedure*)).ti,ab. (67012) 
#11 8 or 11 or 12 (72907) 
#12 7 and 13 (356) 
#13 minim* volume* standard*.mp. (42) 
#14 14 or 15 (398) 
#15 remove duplicates from 16 (314) 
#16 limit 17 to yr="2000 - 2019" (288) 
#17 exp *Hospitals, High-Volume/(1087) 
#18 exp *Hospitals, Low-Volume/(654) 
Total: 288 hits 
 
13.4.4 Search strategy for Embase 
Search Name: Minimum Volume Standards 
Search Date: 12/07/2019 
ID Search 
#1 'surgical volume'/exp 
#2 'hospital volume'/exp    
#3 'high volume hospital'/exp  
#4 'low volume hospital'/exp 
#5 (volume* NEAR/1 outcome*):ti,ab 
#6 ((surgeon* OR surgic* OR surger* OR hospital* OR procedur* OR case OR minim*) NEAR/1 (volume* OR 
'case load*' OR caseload*)):ti,ab 
#7 #1 OR #2 OR #3 OR #4 OR #5 OR #6 
#8 'ambulatory surgery'/exp 
#9 ((ambulatory* OR outpatient* OR day*) NEAR/2 (surge* OR surgic* OR procedure*)):ti,ab 
#10 #8 OR #9  
#11 #7 AND #10  
#12 'minim* volume* standard*':ti,ab,de   
#13 fallzahl* 
#14 mindestfallzahl* 
#15 frequenzregel*  
#16 #12 OR #13 OR #14 OR #15 
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#17 #11 OR #16 
#18 (#11 OR #16) AND [2000-2019]/py 
#19 #18 AND 'conference abstract'/it  
#20 #18 NOT #19 
Total: 346 hits 
 
13.4.5 Search strategy for Livivo 
Date: 12/07/2019 
Freie Suche: (((mindestfallzahl* OR mindestmeng* OR fallzahl* OR frequenzregel*) AND (chirurg* 
OR operat* OR eingriff* OR OP)) AND (Ambula* OR Tages*)) 
Publikationsdatum eingeschränkt auf: 2000-2019 
Total: 33 hits 
 
13.4.6 Search strategy for the hand and exploratory search: 
Search term (optionally) linked with 
English terms 
minimum volume standard* 
volume-outcome relationship 
volume-outcome relation(ship) 























* indicates that also the plural was used in the search 
 

  
 
